TW200909438A - Transition metal complexes with carbene ligands and their application - Google Patents
Transition metal complexes with carbene ligands and their application Download PDFInfo
- Publication number
- TW200909438A TW200909438A TW96132017A TW96132017A TW200909438A TW 200909438 A TW200909438 A TW 200909438A TW 96132017 A TW96132017 A TW 96132017A TW 96132017 A TW96132017 A TW 96132017A TW 200909438 A TW200909438 A TW 200909438A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- substituted
- aromatic
- halogen
- transition metal
- Prior art date
Links
Landscapes
- Electroluminescent Light Sources (AREA)
Abstract
Description
200909438 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種過渡金屬錯合物’特別係關於一種含有碳烯 配位基之過渡金屬錯合物及其於有機電子元件方面之庳用。200909438 IX. INSTRUCTIONS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a transition metal complexes in particular to a transition metal complex containing a carbene ligand and its use in organic electronic components. .
I 【先前技術】 有機發光二極體(〇巧&1^1^汾疋11^咁1^1^0(16,01^0),是指 有機半導體材料和發光材料在電流驅動下達到發光並實現顯示的 技術。有機發光二極體的發光基本原理,是在陰陽兩電極中間置放 發光材料並外加一偏壓,使電子(electron)與電洞(hole)分別經過電 子傳輸層(Electron Transport Layer, ETL)與電洞傳輸層(Hole Transport Layer,HTL)後,進入一具有發光特性的有機物質。電 子與電洞在此有機層内再結合形成一激子(exciton )並將能量釋放 出來而回到基態(ground state ),而這些被釋放出來的能量中, 由於所選擇的發光材料的不同,可使部份能量以不同顏色之光的形 式釋放出來,而達到發光效果。 ‘ 有機三重態(triplet state)發光材料(即有機填光體)近來已成為 OLED材料極重要的發展方向。傳統有機發光材料是屬於發螢光的 單重態(singlet state)發光體,此與發磷光的三重態發光體是不同 的;然而在學理上,磷光材料的電激發光效率是螢光材料的三倍。 一般有機化合物不是沒有磷光,便是很弱,且需在低溫(如77 k 液態氮的溫度)方觀察得到。此限制在一種狀況之下可以破除,即 是在有機化合物化學結構上加上重原子。然而,並非所有的重原子 都有此效果;研究發現,當採用在第六週期的過渡金屬元素,如銖 (Re)、锇(〇s)、銥(Ir)、鉑(Pt)等,效果最佳。 200909438 金屬錯合物最近已被使用作為有機發光二極體的磷光摻雜物 (dopant)。這些被應用在有機發光二極體中發光層的金屬錯合物由 於具重原子效應,引發電子組態具有強的自旋\執域耦合 (spin-orbital coupling),使電子的傳遞可透過金屬-配位基電荷轉移 3MLCT(Metal to Ligand Charge Transfer)和3(7ζ·-τγ*)配位基的混 合’造成單重及三重激發態的混成,因此縮短了三重態的生命期而 提高磷光效率。其中,以含有銥金屬的錯合物最受矚目且廣泛地被 研究。銥金屬的錯合物通常為含有正三價氧化態之正八面體結構, 其放光機制主要是來自於金屬到配位基電荷轉移的三重態 \3MLCT態或是以配位基為主的三重態\3( ▲-▲*)態的放光。 玉衣型玉屬銀·錯化合物(cyclonetalated iridium complexes) 為目前所知具有高效率、高亮度的有機磷光發光二極體材料。I [Prior Art] Organic Light Emitting Diodes (〇巧&1^1^汾疋11^咁1^1^0(16,01^0) means that organic semiconductor materials and luminescent materials are driven by current The technology of illuminating and realizing display. The basic principle of illuminating organic light-emitting diodes is to place a luminescent material between the electrodes of the yin and yang and apply a bias voltage so that electrons and holes pass through the electron transport layer respectively. Electron Transport Layer (ETL) and the Hole Transport Layer (HTL) enter an organic substance with luminescent properties. Electrons and holes are recombined in the organic layer to form an exciton and energy. Released back to the ground state, and the energy released from these, due to the different luminescent materials selected, can release part of the energy in the form of light of different colors to achieve the luminous effect. Organic triplet luminescent materials (ie, organic fillers) have recently become an important development direction for OLED materials. Traditional organic luminescent materials belong to the singlet state of fluorescing. Light body, which is different from phosphorescent triplet illuminant; however, in theory, the electroluminescent light efficiency of phosphorescent material is three times that of fluorescent material. Generally, organic compounds are not without phosphorescence, they are very weak and need Observed at low temperatures (such as the temperature of 77 k liquid nitrogen). This limitation can be broken under one condition, that is, adding heavy atoms to the chemical structure of organic compounds. However, not all heavy atoms have this effect; It is found that when the transition metal elements in the sixth cycle, such as ruthenium (Re), ruthenium (〇s), iridium (Ir), platinum (Pt), etc., are used, the effect is best. 200909438 Metal complex has recently been used. Phosphorescent dopants as organic light-emitting diodes. These metal complexes used in the light-emitting layer of organic light-emitting diodes have a strong spin effect due to heavy atomic effects. Spin-orbital coupling, which allows electron transfer through a mixture of metal-ligand charge transfer 3MLCT (Metal to Ligand Charge Transfer) and 3 (7ζ·-τγ*) ligands to cause single and triple excitation Mixed state Therefore, the lifetime of the triplet state is shortened and the phosphorescence efficiency is improved. Among them, the complex containing a ruthenium metal is most widely studied and widely studied. The complex of the ruthenium metal is usually a regular octahedron containing a positive trivalent oxidation state. Structure, its light-emitting mechanism is mainly from the triplet state of the metal to the ligand charge transfer / 3MLCT state or the triplet state of the ligand -3 ( ▲ - ▲ *) state of the light. The cyclone-formed iridium complexes are known as organic phosphorescent diode materials with high efficiency and high brightness.
Iridium(III) bis(4,6-difluorophenylpyridinato)picolate (FIrpic)為已 知最常見的三重態藍色磷光發光體。儘管以FIrpic所製作的元件在 效率上皆有亮眼的表現,然最大的問題在於色彩的飽和度;其匸圧 座標大致落於(G.16, G.3G),偏高的γ座標值使得光色純度上只達到 藍綠色的範圍,並不.·能達到全彩顯示器所需的深藍色範圍。 2005年%Th〇mpsQn教授發表了以碳料為配位基的新顆銀金 屬錯合物!’2’從放光波長來看是屬於深藍色的發光材料,但是元件 的表現上cIE座標位置卻達到了㈣,G{)6),在色彩飽和度上並不 符合=要求的⑴·15,0·15)甚至是㈣,0.09),而且在效率的表現上 外部篁子效率只達到5_8%,輝度亦只有i7 im/w。另—方面,於 2〇〇5、2_及勒年也有_含·之配位基的 地 被發表,然而在結構上盥Thn I 丨土焉地 教授所發表者並無太大差別, 其不同處僅疋在唆烯配位基上進行不同官能基團的取代而已。 件光有機發光—極體材料發展至今不超過七、八年,而藍色鱗 第8頁 200909438 光的發展更是只有三、四年而已。OLED材料的性能在許多方面都 未臻理想’尤其是較稀少的藍色磷光有機材料。磷光有機發光二極 體材料是近年來讓OLED快速發展與高度受到的期待的一項重要 因素,有機發光二極體白光照明能否實際落實,端賴其中藍色磷光 有機發光二極體材料能否進一步大幅躍進。 綜上所述,藍色填光有機發光二極體材料是讓OLED能否繼無 機半導體LED之後,成為新一代白光照明應用的關鍵。因此,開發 出具有高外部量子效率、高純度、高輝度及高(藍)色彩飽和度的藍 色磷光有機發光二極體材料,實為目前產業界亟需發展的技術。 引用文獻: 1. Sajoto, Tissa; Djurovich, Peter I.; Tamayo, Arnold; Yousufuddin, Muhammed; Bau,Robert; Thompson,Mark E·; Holmes,Russell J·; Forrest,Stephen R· Blue and Near-UV Phosphorescence from Iridium Complexes with Cyclometalated Pyrazolyl or N-Heterocyclic Carbene Ligands. Inorganic Chemistry 2005, 44, 7992-8003. 2. Sajoto, Tissa; Djurovich, Peter I.; Tamayo, Arnold; Yousufuddin, v Muhammed; Bau? Robert; Thompson, Mark E.; Holmes, Russell J.;Iridium(III) bis(4,6-difluorophenylpyridinato)picolate (FIrpic) is the most commonly known triplet blue phosphorescent emitter. Although the components made by FIrpic have a bright performance in terms of efficiency, the biggest problem is the saturation of the color; the 匸圧 coordinates are roughly in (G.16, G.3G), and the high γ coordinate value The color purity is only in the range of blue-green, and it does not reach the deep blue range required for full-color displays. In 2005, Prof. Th〇mpsQn published a new silver metal complex with a carbon material as a ligand; '2' is a dark blue luminescent material from the wavelength of light emission, but the cIE coordinate position of the component However, it has reached (4), G{)6), which does not meet the requirements of (1)·15,0·15) or even (4), 0.09) in terms of color saturation, and the external scorpion efficiency only reaches 5_8 in efficiency performance. %, the brightness is only i7 im/w. On the other hand, in the 2〇〇5, 2_ and Lein years, there is also a place where the ligand of _·· is published. However, there is not much difference in the structure of the professor of Thn I. In the difference, only the substitution of different functional groups on the terpene ligand is carried out. Piece of light organic luminescence - the development of polar materials has not been more than seven or eight years, and the blue scales page 8 200909438 The development of light is only three or four years. The performance of OLED materials is not ideal in many respects, especially the rarer blue phosphorescent organic materials. Phosphorescent organic light-emitting diode materials are an important factor in the rapid development and high expectations of OLEDs in recent years. Whether organic light-emitting diode white light illumination can be practically implemented depends on the blue phosphorescent organic light-emitting diode material. No further leap forward. In summary, the blue-filled organic light-emitting diode material is the key to the new generation of white light illumination applications after enabling OLEDs to follow the semiconductor semiconductor LEDs. Therefore, the development of a blue phosphorescent organic light-emitting diode material having high external quantum efficiency, high purity, high luminance, and high (blue) color saturation is an urgent development technology in the industry. Citations: 1. Sajoto, Tissa; Djurovich, Peter I.; Tamayo, Arnold; Yousufuddin, Muhammed; Bau, Robert; Thompson, Mark E·; Holmes, Russell J·; Forrest, Stephen R· Blue and Near-UV Phosphorescence From Iridium Complexes with Cyclometalated Pyrazolyl or N-Heterocyclic Carbene Ligands. Inorganic Chemistry 2005, 44, 7992-8003. 2. Sajoto, Tissa; Djurovich, Peter I.; Tamayo, Arnold; Yousufuddin, v Muhammed; Bau? Robert; Thompson, Mark E.; Holmes, Russell J.;
Forrest, Stephen R. Saturated deep blue organic electrophosphorescence using a fluorine-free emitter. Applied Physic Letter 2005, 87, 243507. 【發明内容】 根據以上所述之目的,本發明揭露了 一種含有碳細配位基之過 渡金屬錯合物及其在有機電激發光元件中作為主發光體材料 第9頁 200909438 (host material)、電子傳導材料(electronic transport material)、或 是電洞傳導材料(hole transport material)之應用。 本發明之一目的在於提供一種具高度熱穩定性之含有碳烯配 位基之過渡金屬錯合物’以提升有機電子元件之使用壽命。 本發明之另一目的在於提供一学具高的三重態能階差之含有碳 烯配位基之過渡金屬錯合物,可用以補足現有的一般應用於藍色磷光 之主層材料所達不到的能階差,而且通用各類的罐光材料如銀(的、鉑(pt)、 锇(Os)等紅、藍、綠的金屬錯合物材料,進而開發出具有高外部量子效率、 高純度、高輝度及高(藍)色彩飽和度的藍色麟光有機電激發光元件。據此, 進而達到微調放光範圍進而往飽和深藍光色移動之功效。Forrest, Stephen R. Saturated deep blue organic electrophosphorescence using a fluorine-free emitter. Applied Physic Letter 2005, 87, 243507. SUMMARY OF THE INVENTION In accordance with the above objects, the present invention discloses a transition containing a fine carbon ligand Metal complexes and their use as primary illuminant materials in organic electroluminescent devices, page 9, 200909438 (host material), electronic transport materials, or hole transport materials. SUMMARY OF THE INVENTION One object of the present invention is to provide a highly thermally stable transition metal complex containing a carbene ligand to enhance the useful life of an organic electronic component. Another object of the present invention is to provide a transition metal complex containing a carbene ligand having a high triplet energy level difference, which can be used to complement the existing main layer material generally applied to blue phosphorescence. The energy level difference, and general-purpose cans of light materials such as silver, platinum (pt), bismuth (Os) and other red, blue, green metal complex materials, and thus developed high external quantum efficiency, A blue-based organic electroluminescence element with high purity, high luminance, and high (blue) color saturation, thereby achieving the effect of fine-tuning the light-emitting range and moving toward a saturated deep blue color.
之過渡金屬錯合物。上述含有碳烯配位基之過渡金屬錯合物的具有 一化學結構如下之原子團:Transition metal complex. The above transition metal complex containing a carbene ligand has an atomic group having the following chemical structure:
R2 V 2R2 V 2
第10頁 200909438 錯合物可以上述之原子團結構搭配一含有吡啶基多氮化合物來作為輔 助單陰離子雙螯合配位基。據此,本發明藉由引進輔助單陰離子雙螯合配位 基’進而達到促使發光材料在光譜上之放光波長往紅位移方向移動之功效。 本°兒明書亦揭示了上述含有碳烯配位基之過渡金屬錯合物的 應用,特別是應用於有機電激發光元件與/或磷光元件中的主發光 體材粗 電子傳導材料、與電洞傳導材料;或是應用於其他有機電 子元件之電子傳導材料、電洞傳導材料。 【實施方式】 本發明在此所探討的方向為一種含有碳烯配位基的過渡金屬 δ物及其應用。為了能徹底地瞭解本發明,將在下列的描述中提 羊盡的級成結構。顯然地,本發明的施行並未限定於習知該項技 4者所熟習的特殊細節。另一方面,眾所周知的組成並未描述於細 、 X避免造成本發明不必要之限制。本發明的較佳實施例會詳 '、田榀述如下,然而除了這些詳細描述之外,本發明還可以廣泛地施 仃在其他的實施例中’且本發明的範圍不受限定,其以之後的專利 範圍為準。 本發明之第一實施例係揭露一種含有碳烯配位基的過渡金屬 5物’上述含有碳烯配位基的過渡金屬錯合物具有一原子團,上 迷原子團之化學結構可表示如下: 第11頁 200909438Page 10 200909438 The complex compound can be combined with a pyridyl polynitrogen compound as a secondary monoanionic chelating ligand. Accordingly, the present invention achieves the effect of causing the luminescent material to shift in the spectrally shifted wavelength toward the red displacement direction by introducing an auxiliary monoanionic double chelating ligand. The invention also discloses the use of the above transition metal complex containing a carbene ligand, in particular, a main light-emitting material for a basic light-emitting material in an organic electroluminescent device and/or a phosphorescent device, and A hole conducting material; or an electron conducting material or a hole conducting material applied to other organic electronic components. [Embodiment] The direction of the present invention as discussed herein is a transition metal δ containing a carbene ligand and its use. In order to thoroughly understand the present invention, the hierarchical structure will be described in the following description. Obviously, the practice of the present invention is not limited to the specific details familiar to those skilled in the art. On the other hand, well-known compositions are not described in detail, and X avoids unnecessary limitations of the invention. The preferred embodiments of the present invention will be described in detail below, but the present invention can be widely applied in other embodiments except for the detailed description, and the scope of the present invention is not limited, and the following patents The scope shall prevail. The first embodiment of the present invention discloses a transition metal 5 containing a carbene ligand. The above transition metal complex containing a carbene ligand has an atomic group, and the chemical structure of the above atomic group can be expressed as follows: 11 pages 200909438
其中,Μ係為一過渡金屬且係選自下列族群之一者:釘 (ruthenium)、錄(rhodium)、鶴(tungsten)、銖(rhenium)、锇(osmium)、 銥(iridium)、鉑(platinum)。R1係選自下列族群之一者:C1-C20烷 基、C1-C20環炫基、共耗芳香環基團(aromatic group)、雜芳香 雜環基團。R2〜R7可以相同或不同,且R2〜R7係獨立選自下列族 群之一者:氫原子(H)、鹵素原子(例如:氟、氣、溴、碘)、C1-C20 烧基(alkyl group)、C1-C20 環烧基、烧氧基(alkoxyl group)、鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 S旨基(ester group)、C1-C20 酸胺基(amide group)、芳香基、鹵素取代的芳香基 '鹵素取代的芳香烧基、鹵烷 基取代的芳香基、鹵炫基取代的芳香烧基、氰基(cyano)、石肖基 (nitro)、共軛芳香環基團(aromatic group)、芳香雜環基團。 在根據本實施例之一較佳範例中,上述含有碳烯配位基的過渡 金屬錯合物原子團中相鄰之R2與R3、R4與R5、R5與R6、R6與R7 等亦可以至少有一組是形成一芳香環、芳香雜環、環烯基或是雜環 稀基之任意原子團。上述的芳香環、芳香雜環、環烯基或是雜環烯 基等可以分別是五元環、六元環、或是七元環,且上述之芳香環、 第12頁 200909438 芳香雜環、環烯基或是雜環烯基等可以更包含一個或多個取代基。 上述之取代基可以相同或不同,且上述取代基係獨立選自下列族群 中之一者:氫原子、鹵素原子(例如:氟、氯、溴、峨);芳香基、 鹵素取代的芳香基、齒素取代的芳香烷基、齒烷基取代的芳香基、 鹵烷基取代的芳香烷基、芳香基取代的C1_C20烷基;供電子基 (electron donating group)如 C1-C20 烧基、C1-C20 環烧基(例如: 曱基、乙基、丁基、環己基)、C1-C20烧氧基(alkoxy group)、Cl-C20 f \ 取代的胺基(amino group)、具有取代基的芳香胺基[例如苯胺基 (aniline)] ' 或是拉電子基(electron withdrawing group)如鹵素、亞石诗 酸基(nitrile)、硝’基(nitro)、叛基(carbonyl)、氰基(cyano, -CN) 與鹵素取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取代基 團。 上述R2~R7中未成環之取代基可以相同或不同,且上述R2〜 R7中未成環之取代基係獨立選自下列族群之一者:氫原子(H)、鹵 1., 素原子、C1_C20 烷基(alkyl group)、C1-C20 環烷基、烷氧基(alkoxyl group)、鹵素取代的C1-C20烷基、C1-C20取代的胺基(amino group)、Cl_C2(m*(acylgroup)、ci-C20_&(estergr〇up)、C1_C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳 香烷基、lS烷基取代的芳香基、_烷基取代的芳香烷基、氰基 (cyano)、硝基(nitro)、共軛芳香環基團(ar〇matic gr〇up )、芳香雜 環基圑。 第13頁 200909438 參考下式,其所表達者為根據本範例之一過渡金屬錯合物原子 團,其中R2與R3係形成一芳香環之原子團。需注意的是,此一結 構僅係藉以說明本範例,而非用以限制本說明書所揭露之範疇。本 說明書之範圍仍應以其後的專利範圍為準。Wherein, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium, tungsten, rhenium, osmium, iridium, platinum ( Platinum). R1 is selected from one of the group consisting of C1-C20 alkyl, C1-C20 cyclod, aromatic group, heteroaromatic heterocyclic group. R2 to R7 may be the same or different, and R2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom (for example, fluorine, gas, bromine, iodine), a C1-C20 alkyl group (alkyl group). ), C1-C20 cycloalkyl, alkoxyl group, halogen-substituted C1-C20 alkyl, C1-C20 substituted amino group, C1-C20 acyl group, C1- C20 Sester group, C1-C20 amide group, aryl group, halogen-substituted aryl group halogen-substituted aromatic alkyl group, haloalkyl-substituted aryl group, halogen-substituted aromatic group An alkyl group, a cyano group, a nitro group, a conjugated aromatic ring group, and an aromatic heterocyclic group. In a preferred embodiment of the present embodiment, the adjacent R2 and R3, R4 and R5, R5 and R6, R6 and R7, etc. of the transition metal complex containing a carbene ligand may also have at least one The group is any atomic group forming an aromatic ring, an aromatic heterocyclic ring, a cycloalkenyl group or a heterocyclic ring group. The above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above aromatic ring, page 12, 200909438 aromatic heterocyclic ring, The cycloalkenyl group or the heterocycloalkenyl group or the like may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, fluorine, chlorine, bromine, hydrazine); an aryl group, a halogen-substituted aryl group, A dentate-substituted arylalkyl group, a dentate-substituted aryl group, a haloalkyl-substituted arylalkyl group, an aryl-substituted C1_C20 alkyl group; an electron donating group such as a C1-C20 alkyl group, C1- C20 cycloalkyl (for example: mercapto, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group, Cl-C20 f \ substituted amino group, aromatic having a substituent An amine group [e.g., an aniline] ' or an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, a cyano group (cyano) , -CN) a C1-C20 alkyl group substituted with a halogen (for example, a trifluoromethyl group, CF3); a heterocyclic substituent group. The unsubstituted substituents in the above R2 to R7 may be the same or different, and the unsubstituted substituents in the above R2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen 1., a ruthenium atom, a C1_C20 Alkyl group, C1-C20 cycloalkyl group, alkoxyl group, halogen-substituted C1-C20 alkyl group, C1-C20 substituted amino group, Cl_C2 (m*(acylgroup) , ci-C20_&(estergr〇up), C1_C20 amide group, aryl, halogen-substituted aryl, halogen-substituted arylalkyl, lS alkyl-substituted aryl, _alkyl-substituted aromatic An alkyl group, a cyano group, a nitro group, a conjugated aromatic ring group (ar〇matic gr〇up), an aromatic heterocyclic group 圑. Page 13 200909438 refers to the following formula, which is expressed as A transition metal complex atomic group of the present example, wherein R2 and R3 form an atomic group of an aromatic ring. It should be noted that this structure is merely illustrative of the present examples and is not intended to limit the scope of the disclosure. The scope of this specification should still be based on the scope of subsequent patents.
在根據本實施例之另一較佳範例中,上述含有碳烯配位基的過 渡金屬錯合物之結構如下:In another preferred embodiment according to this embodiment, the structure of the above-mentioned transition metal complex containing a carbene ligand is as follows:
其中,Μ係為一過渡金屬且係選自下列族群之一者:釕 (ruthenium)、錢(rhodium)、鶴(tungsten)、銖(rhenium)、餓(osmium)、 銥(iridium)、翻(platinum)。R1係選自下列族群之一者:C1-C20烧 基、C1-C20環烧基、共輛芳香環基團(aromatic group )、雜芳香 雜環基團。R2 ~ R7可以相同或不同,且R2 ~ R7係獨立選自下列族 群之一者:氫原子(H)、鹵素原子(例如:氟、氣、溴、碘)、C1-C20 第14頁 200909438 烧基(alkyl group)、C1-C20 環垸基、烧氧基(aik〇Xyi gr0Up)、鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(arnin〇 group)、C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、鹵烷 基取代的方香基、炫*基取代的方香烧基、氛基(cyano)、®肖基 (nitro)、共軛芳香環基團(aromatic group)、芳香雜環基團。 在根據本範例一較佳實施方式中,上述相鄰之R2與R3、R4 與R5、R5與R6、R6與R7等亦可以至少有一組是形成一芳香環、 芳香雜環、環稀基或是雜環稀基等之任意原子團。上述的芳香環、 芳香雜環、環烯基或是雜環烯基可以分別是五元環、六元環、或是 七元環’且上述芳香環、芳香雜環、環烯基或是雜環稀基可以更包 含一個或多個取代基。 上述R2~R7中未成環之取代基可以相同或不同,且上述r2~ R7中未成環之取代基係獨立選自下列族群之一者:氫原子(Η)、鹵 〔素原子、C1-C20 烷基(alkyl group)、C1-C20 環烷基、烷氧基(alkoxyl group)、ifi素取代的C1-C20烧基、C1-C20取代的胺基(amino group)、Cl-C20 醯基(acyl group)'Cl-C2〇 酯基(ester group)、Cl-C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳 香烧基、鹵烷基取代的芳香基、i燒基取代的芳香烷基、氰基 (cyano)、硝基(nitro)、共軛芳香環基團(ar〇matic gr〇up )、芳香雜 環基團。 第15頁 200909438 根據本範例,上述結構中的z1可以是用於構成含氮雜芳香環 或是含氮雜環浠基之任意原子團。上述之含氮雜芳香環或是含氮雜 環烯基可以是五元環、六元環、戒是七元環,且上述的z1可以更 包含一個或多個取代基。上述之取代基可以相同或不同,且上述取 代基係獨立選自下列族群中之一者:氫原f、鹵素原子(例如:氟、 氯、溴、碘);芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、 鹵烷基取代的芳香基、齒烷基取代的芳香烷基、芳香基取代的 C1-C20 烧基;供電子基(eiectron donating group)如 C1-C20 院 基、C1-C20環烷基(例如:甲基、乙基、丁基 '環己基)、C1-C20 烧氧基(alkoxy group)、C1-C20取代的胺基(amino group)、具有取 代基的芳香胺基[例如苯胺基(aniline)];或是拉電子基(electron withdrawing group)如鹵素、亞硝酸基(nitrile)、硝基(nitro)、羰基 (carbonyl)、氰基(Cyano,-CN)與鹵素取代的C1-C20烧基(例如 三氟甲烷基,CF3);雜環取代基團。 · ;/ 在根據本範例之結構中,Y可以是選自下列族群之一者:氮 (N)、碳(C)、氧(〇)、硫(S)等原子,且Y可以更包含一取代基。Q 係為一至少包含二個原子之原子團,以構成一含氮雜環基團 (heterocyclic ring)。其中Q所包含之原子組合係選自下列族群: 氮、碳、氧、硫。且上述的含氮雜環基團可以更包含一個或多個取 代基。上述之取代基可以相同或不同,且上述取代基係獨立選自下 列族群中之一者:氫原子、鹵素原子(例如.氟、鼠、漠 '峨); 第16頁 200909438 芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、鹵烷基取代的 芳香基、鹵烷基取代的芳香烷基、芳香基取代的C1_C20烷基;供 電子基(electron donating group)如 C1-C20 烧基、C1-C20 環炫基 (例如:曱基、乙基、丁基、環己基)、C1-C20院氧基(alkoxy group)、 C1-C20取代的胺基(amino group)、具有取代基的芳香胺基[例如 苯胺基(aniline)];或是拉電子基(electron withdrawing group)如 鹵素、亞石肖酸基(nitrile)、硝基(nitro)、裁基(carbonyl )、氰基(cyano, -CN)與鹵素取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取 代基團。 在根據本實施例之另一較佳範例中,上述含有石炭稀配位基的過 渡金屬錯合物之結構如下: ~ R6Among them, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium, tungsten, rhenium, osmium, iridium, Platinum). R1 is selected from one of the following groups: a C1-C20 alkyl group, a C1-C20 cycloalkyl group, a total aromatic group, and a heteroaromatic heterocyclic group. R2 ~ R7 may be the same or different, and R2 ~ R7 are independently selected from one of the following groups: hydrogen atom (H), halogen atom (for example: fluorine, gas, bromine, iodine), C1-C20 Page 14 200909438 Burning Alkyl group, C1-C20 cyclodecyl group, alkoxy group (aik〇Xyi gr0Up), halogen-substituted C1-C20 alkyl group, C1-C20 substituted amine group (arnin〇 group), C1-C20 fluorenyl group (acyl group), C1-C20 ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted arylalkyl group, haloalkyl-substituted aryl group, dazzle * A radically substituted aryl, cyano, nitro, aromatic aromatic group, aromatic heterocyclic group. In a preferred embodiment of the present example, the adjacent R 2 and R 3 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 and the like may also form at least one group to form an aromatic ring, an aromatic hetero ring, a ring dilute group or It is an arbitrary atomic group such as a heterocyclic group. The above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or hetero The cycloaliphatic group may further comprise one or more substituents. The unsubstituted substituents in the above R2 to R7 may be the same or different, and the unsubstituted substituents in the above r2 to R7 are independently selected from one of the following groups: a hydrogen atom (Η), a halogen [a atom, a C1-C20). An alkyl group, a C1-C20 cycloalkyl group, an alkoxyl group, an ifi-substituted C1-C20 alkyl group, a C1-C20-substituted amino group, a Cl-C20 fluorenyl group ( Acyl group) 'Cl-C2 ester group, Cl-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aromatic alkyl group, haloalkyl-substituted aryl group, An alkyl group-substituted arylalkyl group, a cyano group, a nitro group, a conjugated aromatic ring group (ar〇matic gr〇up), an aromatic heterocyclic group. Page 15 200909438 According to the present example, z1 in the above structure may be any atomic group for constituting a nitrogen-containing heteroaromatic ring or a nitrogen-containing heterocyclic fluorenyl group. The above nitrogen-containing heteroaromatic ring or nitrogen-containing heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, and the above z1 may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: hydrogenogen f, halogen atom (e.g., fluorine, chlorine, bromine, iodine); aryl, halogen-substituted aryl group , halogen-substituted arylalkyl, haloalkyl-substituted aryl, dentate-substituted arylalkyl, aryl-substituted C1-C20 alkyl; eiectron donating group such as C1-C20 C1-C20 cycloalkyl (for example: methyl, ethyl, butyl 'cyclohexyl), C1-C20 alkoxy group, C1-C20 substituted amino group, aromatic having a substituent An amine group [such as an aniline]; or an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, or a cyano group (Cyano, -CN). a C1-C20 alkyl group substituted with a halogen (for example, a trifluoromethyl group, CF3); a heterocyclic substituent group. In the structure according to the present example, Y may be one selected from the group consisting of nitrogen (N), carbon (C), oxygen (〇), sulfur (S), etc., and Y may further comprise one Substituent. Q is an atomic group containing at least two atoms to constitute a nitrogen-containing heterocyclic ring. The atomic combination contained in Q is selected from the group consisting of nitrogen, carbon, oxygen, and sulfur. And the above nitrogen-containing heterocyclic group may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, fluorine, mouse, desert '峨); Page 16 200909438 Aromatic group, halogen substitution Aromatic group, halogen-substituted arylalkyl group, haloalkyl-substituted aryl group, haloalkyl-substituted arylalkyl group, aryl-substituted C1_C20 alkyl group; electron donating group such as C1-C20 alkyl group , C1-C20 cyclodextrin (eg, decyl, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group, C1-C20 substituted amino group, substituted group An aromatic amine group [such as an aniline]; or an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, or a cyano group. , -CN) a C1-C20 alkyl group substituted with a halogen (for example, a trifluoromethyl group, CF3); a heterocyclic substituent group. In another preferred embodiment according to this embodiment, the structure of the above-mentioned transition metal complex containing a charcoal rare ligand is as follows: ~ R6
其中’ Μ係為一過渡金屬且係選自下列族群之一者:釕 (ruthenium)、錢(rh〇dium)、鶴(tungsten)、鍊(rhenium)、锇(osmium)、 銀(indlum)、鉑(platinum)。R1係選自下列族群之一者:C1-C20烷 基、C1-C20環烧基、共扼芳香環基團(ar〇matic groUp )、雜芳香 雜環基團。R2〜R11可以相同或不同,且R2 ~ R〗1係獨立選自下列 第17頁 200909438 族群之一者:氫原子(Η)、鹵素原子(例如:氟、氯、溴、碘)、C1-C20 烧基(alkyl group)、C1-C20 環烧基、烧氧基(alkoxyl group)、鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(amino group)、C1-C20 醒基(acyl group)、C1-C20 S旨基(ester group)、C1-C20 酿胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、鹵烷 基取代的芳香基、鹵烧基取代的芳香院基、氰基(cyano)、硝基 (nitro)、共輛芳香環基團(aromatic group)、芳香雜環基團。 在根據本範例之一較佳實施方式中,上述相鄰之R2與R3、R4 與 R5、R5 與 R6、R6 與 R7、R8 與 R9、R9 與 R1()、R10 與 R11 等亦可 以至少有一組係形成一芳香環、芳香雜環、環烯基或是雜環烯基等 之任意原子團。上述的芳香環、芳香雜環、環稀基或是雜環烯基等 可以分別是五元環、六元環、或是七元環,且上述芳香環、芳香雜 環、環烯基或是雜環烯基等可以更包含一個或多個取代基。上述芳 香環、芳香雜環、環烯基或是雜環烯基等所包含之取代基可以相同 I 或不同,且獨立選自下列族群之一者:氫原子(H)、鹵素原子(例 如:氟、氯、溴、碘)、C1-C20 烷基(alkyl group)、C1-C20 環烷基、 燒氧基(alkoxyl group)、鹵素取代的C1-C20炫>基、C1-C20取代的 胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 酉旨基(ester group)、C1-C20醯胺基(amide group)、芳香基、鹵素取代的芳香基、 鹵素取代的芳香烷基、鹵烷基取代的芳香基、鹵烷基取代的芳香烷 基、氰基(cyano)、石肖基(nitro)、共輛芳香環基團(aromatic group )、 第18頁 200909438 芳香雜環基團。 上述R2〜R7中未成環之取代基可以相同或不同,且上述R2〜 R7中未成環之取代基係獨立選自下列族群之一者:氫原子(H)、鹵 素原子、C1-C20 烷基(alkyl group)、C1-C20 環烷基、烷氧基(alkoxyl group)、鹵素取代的C1-C20烷基、C1-C20取代的胺基(amino group)'Cl-C20 醯基(acyl group)、Cl-C20 酯基(ester group)、Cl-C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳 f 香烷基、鹵烷基取代的芳香基、_烷基取代的芳香烷基、氰基 (cyano)、硝基(nitro)、共軛芳香環基團(aromatic gr〇up )、芳香雜 環基團。 在根據本範例之結構中’ Y係選自下列族群之一者:氮(N)、 碳(C) '氧(Ο)、硫(S)等原子,且Y可以更包含一取代基。Q係為 一至少包含一個原子之原子團’以構成一含氮雜環基團 (heterocyclic ring)。Q所包含之原子組合可以是選自下列族群之 ( 中:氮、碳、氧、硫等原子。且上述的含氮雜環基團可以更包含一 個或多個取代基。上述之取代基可以相同或不同,且上述取代基係 獨立選自下列族群中之一者:氫原子、鹵素原子(例如:敦、氯、 漠、峨);芳香基、鹵素取代的芳香基、鹵素取代的芳香燒美、齒 烷基取代的芳香基、鹵烷基取代的芳香烷基、芳香基取代的cl_C2〇 烷基;供電子基(electron donatinggroup)如 C1-C20 烷基、clC2〇 環烷基(例如:曱基、乙基、丁基、環己基)、C1-C20烷氡基(alk〇xy 第19頁 200909438 group)、C1-C20取代的胺基(amino group)、具有取代基的芳香胺基 [例如苯胺基(aniline)]、或是拉電子基(electron withdrawing group) 如鹵素、亞硝酸基(nitrile)、硝基(nitro)、羰基(carbonyl)、氰基 (cyano,-CN)與鹵素取代的C1-C20烧基(例如三氟甲烧基,CF3); 雜環取代基團。 根據本實施例之又一範例係揭露一種從過渡金屬雙聚物形成 一含有碳烯配位基之過渡金屬錯合物的反應流程。前述之反應流程 係可表示如下:Where 'the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rh〇dium, tungsten, rhenium, osmium, silver (indlum), Platinum. R1 is selected from one of the following groups: a C1-C20 alkyl group, a C1-C20 cycloalkyl group, a conjugated aromatic ring group (ar〇matic groUp), a heteroaromatic heterocyclic group. R2 to R11 may be the same or different, and R2 to R1 are independently selected from one of the following 200909438 ethnic groups: a hydrogen atom (Η), a halogen atom (for example, fluorine, chlorine, bromine, iodine), C1- C20 alkyl group, C1-C20 cycloalkyl, alkoxyl group, halogen-substituted C1-C20 alkyl, C1-C20 substituted amino group, C1-C20 awake ( Acyl group), C1-C20 S ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aryl group, haloalkyl-substituted aryl group, A halogen-based aromatic aroma group, a cyano group, a nitro group, a total aromatic group, and an aromatic heterocyclic group. In a preferred embodiment of the present example, the adjacent R2 and R3, R4 and R5, R5 and R6, R6 and R7, R8 and R9, R9 and R1(), R10 and R11, etc. may also have at least one The group forms an arbitrary atomic group such as an aromatic ring, an aromatic heterocyclic ring, a cycloalkenyl group or a heterocyclic alkenyl group. The above aromatic ring, aromatic heterocyclic ring, cycloaliphatic group or heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above aromatic ring, aromatic heterocyclic ring or cycloalkenyl group or The heterocyclenyl group or the like may further contain one or more substituents. The substituents contained in the above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be the same or different and independently selected from one of the following groups: a hydrogen atom (H), a halogen atom (for example: Fluorine, chlorine, bromine, iodine), C1-C20 alkyl group, C1-C20 cycloalkyl group, alkoxyl group, halogen-substituted C1-C20 danic group, C1-C20 substituted Amino group, C1-C20 acyl group, C1-C20 ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen substitution Aromatic alkyl, haloalkyl-substituted aryl, haloalkyl-substituted arylalkyl, cyano, nitro, aromatic group, page 18 200909438 aromatic Ring group. The unsubstituted substituents in the above R2 to R7 may be the same or different, and the unsubstituted substituents in the above R2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom, a C1-C20 alkyl group. (alkyl group), C1-C20 cycloalkyl, alkoxyl group, halogen-substituted C1-C20 alkyl, C1-C20 substituted amino group 'Cl-C20 acyl group , Cl-C20 ester group, Cl-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aryl-f-alkyl group, haloalkyl-substituted aryl group, _ alkane A substituted arylalkyl group, a cyano group, a nitro group, a conjugated aromatic ring group (aromatic gr〇up), an aromatic heterocyclic group. In the structure according to the present example, the Y-line is selected from one of the following groups: nitrogen (N), carbon (C) 'oxygen (oxime), sulfur (S), and the like, and Y may further contain a substituent. The Q system is an atomic group containing at least one atom to constitute a nitrogen-containing heterocyclic ring. The atomic combination contained in Q may be an atom selected from the group consisting of nitrogen, carbon, oxygen, sulfur, etc., and the above nitrogen-containing heterocyclic group may further contain one or more substituents. The same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, Dun, Chlorine, Mo, 峨); an aryl group, a halogen-substituted aryl group, a halogen-substituted aromatic group. Aromatic, dentate-substituted aryl, haloalkyl-substituted arylalkyl, aryl-substituted cl_C2 decyl; electron donating group such as C1-C20 alkyl, clC2 〇cycloalkyl (eg: Sulfhydryl, ethyl, butyl, cyclohexyl), C1-C20 alkanoyl (alk〇xy, p. 19, 200909438 group), C1-C20 substituted amino group, substituted aromatic amine group [ For example, an aniline, or an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, a cyano group (CN), and a halogen. C1-C20 alkyl (eg, trifluoromethane, CF3); heterocycle A further example according to this embodiment is a reaction scheme for forming a transition metal complex containing a carbene ligand from a transition metal dimer. The foregoing reaction scheme can be expressed as follows:
22
其中,Μ係為一過渡金屬且係選自下列族群之一者:釕 (ruthenium)、姥(rhodium)' 鎢(tungsten)、銖(rhenium)、娥(osmium)、 銥(iridium)、鉑(platinum)。R1係選自下列族群之一者:C1-C20烷 第20頁 200909438 基C1-C20環烧基、共輕芳香環基團(㈣細舰p)、雜芳香 基團° R〜R可以相同或不同,且r2 ~ r7係、獨立選自下列族 群之者.氫原子出)、_素原子⑼如:氣、氣、漠d'ci_c2〇 烷基(alkyl group)、Cl_C2〇環烷基、烷氧基⑷匕⑴^ gr〇up)、鹵素 取代的C1-C20 基、Cuc2〇取代的胺基_in〇 的、ci c2〇 醢基(acyl group)、C1-C20 酯基(estergr〇up)、cl C2〇 醯胺基(amide group)、芳香基、鹵素取代的芳香基、画素取代的芳香烧基、齒烧 基取代的方香基、i燒基取代的芳香烷基、氰基(cyan〇)、硝基 (miro)、共軛芳香%、基團(ar〇刪心哪)、芳香雜環基團。 在根據本範例之-較佳實施方式中,上述相鄰之r2與r3、r4 與R、R與R、R 1% r7等亦可以至少有一組係形成一芳香環、 芳香雜ί衣、ί衣烯基或是雜環烯基之任意原子團。上述的芳香環、芳 香雜壤、壞稀基或是雜環稀基可以分別是五元環'六元環、或是七 70% ’且上述芳香壤、芳香雜環、環烯基或是雜環烯基等可以更包 I 含一個或多個取代基。上述之取代基可以相同或不同,且上述取代 基係獨立選自下列族群中之一者:氫原子、鹵素原子(例如:氟、 氣、溴、碘);芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、 鹵烷基取代的芳香基、齒烷基取代的芳香烷基、芳香基取代的 C1-C20 烧基,供電子基(electron donating group)如 C1-C20 烧 基、C1-C20環烷基(例如:甲基、乙基、丁基、環己基)、C1_C20 烷氧基(alkoxy group)、C1-C20取代的胺基(amino group)、具有取 第21頁 200909438 代基的芳香胺基[例如苯胺基(aniline)]、或是拉電子基(electron withdrawing group)如鹵素、亞硝酸基(nitriie)、硝基(nitro)、羰基 (carbonyl)、氰基(cyan〇,_CN)與鹵素取代的C1-C20烷基(例如 二鼠曱烧基,CF3),雜環取代基團。 上述R2〜R7中未成環之取代基可以相同或不同,且上述r2~ R7中未成環之取代基係獨立選自下列族群之一者:氫原子(H)、鹵 素原子、C1-C20 烷基(aikyl group)、Cl-C20 環烷基、烷氧基(alkoxyl group)、齒素取代的C1_C20烷基、cl_C2〇取代的胺基(amin〇 group)、Ci-C20 醯基(aCyi group)、C1_C2〇 g旨基(ester gr〇up)、ci c2〇 醯胺基(amide group)'芳香基、鹵素取代的芳香基、鹵素取代的芳 香烷基、_烷基取代的芳香基、_烷基取代的芳香烷基、氰基 (cyano) '硝基(nitro)、共軛芳香環基團(ar〇matic 0〇叩)、芳香雜 環基團。 根據本範例,上述結構中的χ係一 _素原子,例如氣、溴、 姨寻原子。Ζ2可以是用於構成含氮雜芳香環或是含氮雜環稀基之 任意原子團。上述之含氮雜芳香環或是含氮雜環烯基可以是五元 %、/、騎、或是七兀環,且上述的ζ2可以更包含—個或多個取 代基。上述之取代基可以相同或不同,且上述取代基係獨立選自下 列族群中之-者:氫原子、㈣原子(例如:氟、氣、漠、蛾广 芳香基、i素取代的芳香基、“取代的芳㈣基' ^基取代的 方曰基、_烧基取代的芳香院基、芳香基取代的ci_c2〇烧基;供 第22頁 200909438 電子基(electron donating group)如 C1-C20 烧基、C1-C20 環烷基 (例如:甲基、乙基、丁基、環己基)、C1-C20烷氧基(alkoxy group)、 C1-C20取代的胺基(amino group)、具有取代基的芳香胺基[例如 苯胺基(aniline)];拉電子基(electron withdrawing group)如鹵素、 亞硝酸基(nitrile)、硝基(nitro)、羰基(carbonyl )、氰基(cyano,-CN) 與鹵素取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取代基 團。 在根據本範例之結構中,Y係選自下列族群之一者:氮(N)、 碳(C)、氧(0)、硫(S)等原子。Y可以更包含一取代基。Q係為一至 少包含二個原子之原子團,以構成一含氮雜環基團(heterocyclic ring)。其中Q所包含之原子組合係選自下列族群:氮、碳、氧、 硫。且上述的含氮雜環基團可以更包含一個或多個取代基。上述之 取代基可以相同或不同,且上述取代基係獨立選自下列族群中之一 者:氳原子、鹵素原子(例如:氟、氯、溴、碘);芳香基..、_素 取代的芳香基、鹵素取代的芳香烷基'鹵烷基取代的芳香基、鹵烷 基取代的芳香烷基' 芳香基取代的C1-C20烷基;供電子基 (electron donating group)如 C1-C20 烷基、C1-C20 環烷基(例如: 曱基、乙基、丁基、環己基)、C1-C20烷氧基(alkoxy group)' C1-C20 取代的胺基(amino group)、具有取代基的芳香胺基[例如苯胺基 (aniline)];拉電子基(electron withdrawing group)如鹵素、亞硝酸基 (nitrile)、硝基(nitro)、羰基(carbonyl )、氰基(cyano, -CN)與鹵素 第23頁 200909438 取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取代基團。 根據本實施例,前述之芳香基團可以是包含苯基(phenyl)、萘 基(naphthyl)、聯苯基(diphenyl)、蒽基(anthryl)、苯并菲基(pyrenyl)、 菲基(phenanthryl)與苐基(fluorenyl)或其他形式之多苯環取代基。 前述的環稀基團包含環己烯(cyclohexene)、環己二稀 (cyclohexadiene)、環戊烯(cyclopentene)與環戊二烯 (cyclopentadiene)或其他形式之環烯。前述之雜環基團包括哌喃 (pyrane)、旅咯琳(pyrroline)、呋喃(furan)、苯并吱喃(benzofuran)、 11 塞吩(thiophene)、苯并》塞口分(benzothiophene)' 口比淀(pyridine)、口奎琳 (quinoline)、異喧淋(isoquinoline)、吼 0秦(pyrazine)、°密 〇定 (pyrimidine)、》比洛(pyrrole)、口比。坐(pyrazole)、口米 口坐(imidazole)、。引 0朵(indole)、α塞。坐(thiazole)、異 ^°^(isothiazole)、σ惡唾(oxazole)、 異°惡唾(isoxazole)、苯并α塞唾(benzothiazole)、苯并°惡唾 (benzoxazole)、二氮菲(phenanthroline)或其他形式之雜環。前述的 (含氣雜環基團包含。比α定(pyridine)、啥琳(quinoline)、異啥琳 (isoquinoline)、口比 口秦(pyrazine)、〇密唆(pyrimidine)、n比咯(pyrrole) ' 0比0坐(pyrazole)、0米唾(imidazole)、°引°朵(indole) ' °塞 α坐(thiazole)、 異0塞。坐(isothiazole)、σ惡唆(oxazole)、異 °,%^(isoxazole)、苯并嗟峻 (benzothiazole)、苯并嗯嗤(benzoxazole)與二氮菲(phenanthroline) 或其他形式之雜環。 在根據本範例之一較佳實施方式中,上述之反應流程可表示 第24頁 200909438Wherein, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium 'tungsten, rhenium, osmium, iridium, platinum ( Platinum). R1 is selected from one of the following groups: C1-C20 alkane page 20 200909438 base C1-C20 cycloalkyl, co-light aromatic ring group ((four) fine ship p), heteroaromatic group ° R~R may be the same or Different, and r2 ~ r7 series, independently selected from the following groups: hydrogen atom), _ atom (9) such as: gas, gas, desert d'ci_c2 alkyl group, Cl_C2 〇 cycloalkyl, alkane Oxygen (4) 匕(1)^ gr〇up), halogen-substituted C1-C20 group, Cuc2〇 substituted amino group _in〇, ci c2 acyl group, C1-C20 ester group (estergr〇up) , cl C2 amide group, aryl group, halogen-substituted aryl group, pixel-substituted aromatic alkyl group, dentate-substituted aryl group, i-alkyl-substituted arylalkyl group, cyano group (cyan〇) , nitro (miro), conjugated aromatic %, group (ar 〇 〇), aromatic heterocyclic group. In the preferred embodiment according to the present example, the adjacent r2 and r3, r4 and R, R and R, R 1% r7, etc. may also form at least one group to form an aromatic ring, aroma, and Any group of alkenyl groups or heterocycloalkenyl groups. The above aromatic ring, aromatic heterodish, bad dilute or heterocyclic dilute group may be a five-membered ring 'six-membered ring, or seven 70%', and the above aromatic, aromatic, cycloalkenyl or heterocyclic The cycloalkenyl group or the like may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, fluorine, gas, bromine, iodine); an aromatic group, a halogen-substituted aromatic group, Halogen-substituted arylalkyl, haloalkyl-substituted aryl, dentate-substituted arylalkyl, aryl-substituted C1-C20 alkyl, electron donating group such as C1-C20 alkyl, C1 -C20 cycloalkyl (eg methyl, ethyl, butyl, cyclohexyl), C1_C20 alkoxy group, C1-C20 substituted amino group, having the 200909438 generation on page 21 An aromatic amine group [such as an aniline], or an electron withdrawing group such as a halogen, a nitriie, a nitro group, a carbonyl group, or a cyano group (cyan〇, _CN) a C1-C20 alkyl group substituted with a halogen (e.g., diterpenoid, CF3), a heterocyclic substituent group. The unsubstituted substituents in the above R2 to R7 may be the same or different, and the unsubstituted substituents in the above r2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom, a C1-C20 alkyl group. (aikyl group), Cl-C20 cycloalkyl, alkoxyl group, dentate-substituted C1_C20 alkyl group, cl_C2〇 substituted amino group (amin〇 group), Ci-C20 fluorenyl group (aCyi group), C1_C2〇g基基(ester gr〇up), ci c2 amide group 'aryl group, halogen-substituted aryl group, halogen-substituted arylalkyl group, _alkyl-substituted aryl group, _alkyl group Substituted aromatic alkyl, cyano 'nitro", conjugated aromatic ring group (ar〇matic 0), aromatic heterocyclic group. According to the present example, the lanthanide atoms in the above structure, such as gas, bromine, and ruthenium atoms. Ζ2 may be any atomic group used to constitute a nitrogen-containing heteroaromatic ring or a nitrogen-containing heterocyclic ring. The above nitrogen-containing heteroaromatic ring or nitrogen-containing heterocycloalkenyl group may be a 5%, /, or a heptacyclic ring, and the above oxime 2 may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from the group consisting of a hydrogen atom and a (iv) atom (for example, fluorine, gas, desert, moth-aromatic, i-substituted aromatic group, "Substituted aryl(tetra)yl'-yl-substituted aryl fluorenyl, aryl-substituted aroma-based, aryl-substituted ci_c2 fluorenyl; for page 22 200909438 electron donating group such as C1-C20 a C1-C20 cycloalkyl group (e.g., methyl, ethyl, butyl, cyclohexyl), a C1-C20 alkoxy group, a C1-C20 substituted amino group, having a substituent Aromatic amine group [eg aniline]; electron withdrawing group such as halogen, nitrile, nitro, carbonyl, cyano, -CN a C1-C20 alkyl group substituted with a halogen (for example, a trifluoromethyl group, CF3); a heterocyclic substituent group. In the structure according to the present example, the Y group is selected from one of the following groups: nitrogen (N), carbon ( C), oxygen (0), sulfur (S) and other atoms. Y may further comprise a substituent. Q is an atomic group containing at least two atoms To form a nitrogen-containing heterocyclic ring, wherein the atomic combination contained in Q is selected from the group consisting of nitrogen, carbon, oxygen, sulfur, and the above nitrogen-containing heterocyclic group may further comprise one or a plurality of substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a halogen atom, a halogen atom (for example, fluorine, chlorine, bromine, iodine); an aromatic group: , a substituted aryl group, a halogen-substituted arylalkyl 'haloalkyl-substituted aryl group, a haloalkyl-substituted arylalkyl' aryl-substituted C1-C20 alkyl group; an electron donating group Such as C1-C20 alkyl, C1-C20 cycloalkyl (eg: decyl, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group 'C1-C20 substituted amine (amino group) An aromatic amine group having a substituent [e.g., an aniline]; an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, a cyano group ( Cyano, -CN) and halogen on page 23 200909438 substituted C1-C20 alkyl (eg trifluoromethyl) Base, CF3); heterocyclic substituent group. According to this embodiment, the aforementioned aromatic group may be composed of phenyl, naphthyl, diphenyl, anthryl, benzene. And pyrenyl, phenanthryl and fluorenyl or other forms of polyphenyl ring substituents. The aforementioned ring-thin group includes cyclohexene, cyclohexadiene, cyclopentene and cyclopentadiene or other forms of cycloolefin. The aforementioned heterocyclic groups include pyrane, pyrroline, furan, benzofuran, 11 thiophene, benzothiophene. Pyridine, quinoline, isoquinoline, pyrazine, pyrimidine, pyrrole, mouth ratio. Sitting on (pyrazole), mouth rice (imidazole). Introduce 0 (indole), alpha plug. Thiazole, isothiazole, oxazole, isoxazole, benzothiazole, benzoxazole, phenanthroline Phenanthroline) or other forms of heterocyclic ring. The aforementioned (gas-containing heterocyclic group includes: pyridine, quinoline, isoquinoline, pyrazine, pyrimidine, n-pyrrol ( Pyrrole) ' 0 to 0 (pyrazole), 0 m salim (imidazole), ° 引 (indole) ' ° α α (thiazole), 0 0 塞. sitting (isothiazole), σ ox (oxazole), Iso, %^(isoxazole), benzothiazole, benzoxazole and phenanthroline or other forms of heterocyclic rings. In a preferred embodiment according to one example, The above reaction process can be expressed on page 24 200909438
族群之一者:氫原子(Η)、鹵素原子(例如:氟、氯、溴、碘)、C1-C20 烧基(alkyl group)、C1-C20 環烧基、氧基(alkoxyl group)、鹵素 取代的 C1-C20 烧基、C1-C20 取代的胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 醋基(ester group)、C1-C20 酸胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、鹵烷 基取代的芳香基、鹵烷基取代的芳香烷基、氰基(cyano)、硝基 (nitro)、共幸厄芳香環基團(aromatic group )、芳香雜環基團。 在根據本範例之一較佳實施方式中,上述相鄰之R8與R9、R9 與R1G、R1Q與R11等亦可以至少有一組係形成一芳香環、芳香雜環、 環烯基或是雜環烯基之任意原子團。上述的芳香環、芳香雜環、環 浠基或是雜環烯基等可以分別是五元環、六元環、或是七元環,且 第25頁 200909438 上述芳香環 '芳香雜環、環烯基或是雜環烯基等可以更包含一個或 多個取代基。上述芳香環、芳香雜環、環烯基或是雜環烯基等之取 代基可以相同或不同,且係獨立選自下列族群之一者:氫原子(H)、 鹵素原子(例如:氟、氯、漠、破)、c卜C20烧基(alkyl group)、 C1-C20環烧基、炫氧基(alkoxyl group)、鹵素取代的C1-C20烧基、 C1-C20取代的胺基(amino group)'C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20醯胺基(amide group)、芳香基、鹵素取 ' 代的芳香基、鹵素取代的芳香烷基、鹵烷基取代的芳香基、鹵炫*基 取代的芳香烧基、氰基(cyan〇)'硝基(nitro)、共輛芳香環基團 (aromatic group )、芳香雜環基團。 上述r8~r"中未成環之取代基可以相同或不同,且上述r8~ R11中未成環之取代基係獨立選自下列族群之一者:氫原子(H)、函 素原子、C1-C20 炫*基(alkyl group)、C1-C20 環烧基、烧氧基(alk〇xyl group)、鹵素取代的C1-C20烷基、CrC20取代的胺基(amin〇 ( group)、C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳 香烷基、鹵烷基取代的芳香基、鹵烷基取代的芳香烷基、乳基 (cyano)、硝基(nitro)、共軛芳香環基團(aromatic group )、芳香雜 環基團。 以下將揭示數種根據本實施例之含有碳烯配位基的過渡金属 錯合物之結構。然而,本說明書之範圍仍應以其後的專利範園 第26頁 200909438 為準,而不應以下列所揭示範例為限。 i.One of the ethnic groups: hydrogen atom (Η), halogen atom (for example: fluorine, chlorine, bromine, iodine), C1-C20 alkyl group, C1-C20 cycloalkyl, alkoxyl group, halogen Substituted C1-C20 alkyl, C1-C20 substituted amino group, C1-C20 acyl group, C1-C20 ester group, C1-C20 amide group , an aryl group, a halogen-substituted aryl group, a halogen-substituted arylalkyl group, a haloalkyl-substituted aryl group, a haloalkyl-substituted arylalkyl group, a cyano group, a nitro group, a co-fortunate fragrance Aromatic group, aromatic heterocyclic group. In a preferred embodiment of the present example, the adjacent R8 and R9, R9 and R1G, R1Q and R11, and the like may also form at least one group to form an aromatic ring, an aromatic heterocyclic ring, a cycloalkenyl group or a heterocyclic ring. Any atomic group of an alkenyl group. The above aromatic ring, aromatic heterocyclic ring, cyclodecyl group or heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above-mentioned aromatic ring 'aromatic heterocyclic ring and ring number on page 25 200909438 The alkenyl group or the heterocyclic alkenyl group or the like may further contain one or more substituents. The substituents of the above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be the same or different and are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom (for example, fluorine, Chlorine, desert, broken), c-C20 alkyl group, C1-C20 cycloalkyl, alkoxyl group, halogen-substituted C1-C20 alkyl, C1-C20 substituted amine Group) 'C1-C20 acyl group, C1-C20 ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aryl group a halogen group substituted with a haloalkyl group, an aromatic alkyl group substituted with a halogenoyl group, a cyano group, a nitro group, an aromatic group, and an aromatic heterocyclic group. The unsubstituted substituents in the above r8~r" may be the same or different, and the unsubstituted substituents in the above r8 to R11 are independently selected from one of the following groups: a hydrogen atom (H), a functional atom, and a C1-C20. An alkyl group, a C1-C20 cycloalkyl group, an alkoxy group (alk〇xyl group), a halogen-substituted C1-C20 alkyl group, a CrC20 substituted amine group (amin〇 group, C1-C20 醯) Acyl group, C1-C20 ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aryl group, haloalkyl-substituted aryl group a haloalkyl-substituted arylalkyl group, a cyano group, a nitro group, a conjugated aromatic ring group, an aromatic heterocyclic group. Several kinds of contents according to the present embodiment will be disclosed below. The structure of the transition metal complex of the carbene ligand. However, the scope of this specification should be based on the subsequent patent specification, page 26, 200909438, and should not be limited to the examples disclosed below.
Ir(fpmi)2(tfptz)Ir(fpmi)2(tfptz)
Ir(pmi)2(tfpypz)Ir(pmi)2(tfpypz)
Ir(fpmi)2(tfpypz)Ir(fpmi)2(tfpypz)
\=J\=J
Ir(pmi)2(pytz)Ir(pmi)2(pytz)
Ir(fpmi)2(pytz)Ir(fpmi)2(pytz)
Ir(fpmi)2(pytrz) 第27頁 200909438Ir(fpmi)2(pytrz) Page 27 200909438
\=j b*(mpmi)2(mptz)\=j b*(mpmi)2(mptz)
Ir(mpmi)2(pypz)Ir(mpmi)2(pypz)
Ir(mpmi)2(tfpypz)Ir(mpmi)2(tfpypz)
Jr(mpmi)2(pytz)Jr(mpmi)2(pytz)
|r(mmpmi)2(mptz)|r(mmpmi)2(mptz)
Ir(mmpmi)2(pypz)Ir(mmpmi)2(pypz)
Ir(mmpmi)2(tfpypz)Ir(mmpmi)2(tfpypz)
第28頁 200909438Page 28 200909438
FF
FF
FF
lr(mfpmi)2(pytz)Lr(mfpmi)2(pytz)
FF
Ir(mfpmi)2(tfptz) FIr(mfpmi)2(tfptz) F
Ir(mfpmi)2(tfpypz)Ir(mfpmi)2(tfpypz)
FF
MeOMeO
Ir(mompmi)2(mptz)Ir(mompmi)2(mptz)
MeOMeO
MeOMeO
Ir(mompmi)2(pytz)Ir(mompmi)2(pytz)
MeOMeO
rr(mompmi)2(pypz)Rr(mompmi)2(pypz)
MeOMeO
Ir(mompmi)2(tfpypz)Ir(mompmi)2(tfpypz)
MeOMeO
第29頁 200909438Page 29 200909438
Ir(dmpmi)2(mptz) Ir(dmpmi)2(tfptz) Ir(dmpmi)2(pytz)Ir(dmpmi)2(mptz) Ir(dmpmi)2(tfptz) Ir(dmpmi)2(pytz)
Ir(dmpmi)2(pypz) Ir(dmpmi)2(tfpypz)Ir(dmpmi)2(pypz) Ir(dmpmi)2(tfpypz)
Ir(dmpmi)2(pytrz) 第30頁 200909438Ir(dmpmi)2(pytrz) Page 30 200909438
合 F — F —F - F —
Ir(dfpmi)2(mptz) Ir(dfpmi)2(tfptz) Ir(dfpmi)2(pytz)Ir(dfpmi)2(mptz) Ir(dfpmi)2(tfptz) Ir(dfpmi)2(pytz)
Ir(dfpmi)2(pypz)Ir(dfpmi)2(pypz)
Ir(dfpmi)2(tfpypz)Ir(dfpmi)2(tfpypz)
Ir(dfpmi)2(pytrz)Ir(dfpmi)2(pytrz)
第31頁 200909438Page 31 200909438
lr3 Ir(dfpmi)2(tfptz)Lr3 Ir(dfpmi)2(tfptz)
^r3 Ir(dfpmi)2(pytz)^r3 Ir(dfpmi)2(pytz)
Ir(dfpmi)2(pytrz)Ir(dfpmi)2(pytrz)
Ir(nmi)2(tfptz)Ir(nmi)2(tfptz)
第32頁 200909438Page 32 200909438
第33頁 200909438Page 33 200909438
第34頁 200909438Page 34 200909438
Ir(bmpi)2(pytz)Ir(bmpi)2(pytz)
第35頁 200909438Page 35 200909438
Ir(bmopi)2(mptz)Ir(bmopi)2(mptz)
第36頁 200909438Page 36 200909438
Ir(bmfpi)2(mptz)Ir(bmfpi)2(mptz)
第37頁 200909438Page 37 200909438
MeO MeO MeOMeO MeO MeO
第38頁 200909438 fPage 38 200909438 f
Ir(bdfpi)2(pytz)Ir(bdfpi)2(pytz)
Ir(bdfpi)2(pytrz)Ir(bdfpi)2(pytrz)
第39頁 200909438Page 39 200909438
第40頁 200909438Page 40 200909438
Ir(mmpmi)2(你tz)Ir(mmpmi)2 (you tz)
Ir(mmpmi)2(pytz) 第41頁 200909438Ir(mmpmi)2(pytz) Page 41 200909438
Ir(mmpmbi)2(tfpypz)Ir(mmpmbi)2(tfpypz)
Ir(mmpmbi)2(pytrz)Ir(mmpmbi)2(pytrz)
Ir(mfpmbi)2(pypz)Ir(mfpmbi)2(pypz)
FF
Ir(mfpmbi)2(pytz)Ir(mfpmbi)2(pytz)
Ir(mfpmbi)2(tfpypz)Ir(mfpmbi)2(tfpypz)
Ir(mfpmbi)2(pytrz)Ir(mfpmbi)2(pytrz)
Ir(pmbi)2(mptz)Ir(pmbi)2(mptz)
、、N〆 0,,N〆 0
Ir(pmbi)2(pytz) 第42頁 200909438Ir(pmbi)2(pytz) Page 42 200909438
CFCF
Ir(pmbi)2(pypz) Q:Ir(pmbi)2(pypz) Q:
//
Ir(pmbi)2(tfpypz) Ir(pmbi)2(pytrz)Ir(pmbi)2(tfpypz) Ir(pmbi)2(pytrz)
Ir(fpmbi)2(tfptz)Ir(fpmbi)2(tfptz)
Ir (fpmbi)2(mp tz)Ir (fpmbi) 2 (mp tz)
Ir(ft»mbi)2(pytz)Ir(ft»mbi)2(pytz)
Ir(fpmbi)2(pytrz)Ir(fpmbi)2(pytrz)
Ir(fpmbi)2(pypz)Ir(fpmbi)2(pypz)
Ir(fpmbi)2(tfpypz)Ir(fpmbi)2(tfpypz)
Ir(dmpmbi)2(pytz) 第43頁 200909438 〆Ir(dmpmbi)2(pytz) Page 43 200909438 〆
Ir(dfpmbi)2(pypz)Ir(dfpmbi)2(pypz)
Ir(dmpmbi)2(pytrz)Ir(dmpmbi)2(pytrz)
Ir(dfpmbi)2(pytrz)Ir(dfpmbi)2(pytrz)
Ir(dmopmbi)2(mptz)Ir(dmopmbi)2(mptz)
Ir(dmopmbi)2(tfptz)Ir(dmopmbi)2(tfptz)
Ir(dmopmbi)2(pytz) 第44頁 200909438Ir(dmopmbi)2(pytz) Page 44 200909438
Ir(dmopmbi)2(pypz)Ir(dmopmbi)2(pypz)
Ir(dfpmbi)2(tfptz) Ir(dfpmbi)2(pytz)Ir(dfpmbi)2(tfptz) Ir(dfpmbi)2(pytz)
Ir(dfpmbi)2(pypz)Ir(dfpmbi)2(pypz)
Ir(dfpmbi)2(tfpypz) Ir(dfpmbi)2(pytrz)Ir(dfpmbi)2(tfpypz) Ir(dfpmbi)2(pytrz)
Ir(nmbi)2(mptz) Ir(nmbi)2(tfptz) Ir(nmbi)2(pytz) 第45頁 200909438Ir(nmbi)2(mptz) Ir(nmbi)2(tfptz) Ir(nmbi)2(pytz) Page 45 200909438
Ir(nmbi)2(pypz)Ir(nmbi)2(pypz)
Ir(nmbi)2(pytrz)Ir(nmbi)2(pytrz)
Ir(pnmbi)2(mptz)Ir(pnmbi)2(mptz)
Ir(pnmbi)2(pytz)Ir(pnmbi)2(pytz)
Ir(pnmbi)2(pypz)Ir(pnmbi)2(pypz)
Ir(pnmbi)2(pytrz)Ir(pnmbi)2(pytrz)
Ir(bpbi)2(mptz)Ir(bpbi)2(mptz)
Ir(pnmbi)2(tfpypz)Ir(pnmbi)2(tfpypz)
Ir(bpbi)2(pytz) 第46頁 200909438Ir(bpbi)2(pytz) Page 46 200909438
Ir(pymbi)2(tfptz) Ir(pymbi)2(pytz)Ir(pymbi)2(tfptz) Ir(pymbi)2(pytz)
第47頁 200909438Page 47 200909438
Ir(bmpbi)2(tfptz)Ir(bmpbi)2(tfptz)
Ir(bmpbi)2(mptz)Ir(bmpbi)2(mptz)
Ir(bmpbi)2(pytrz)Ir(bmpbi)2(pytrz)
Ir(bfpbi)2(pytrz) 第48頁 200909438Ir(bfpbi)2(pytrz) Page 48 200909438
Ir(bmopbi)2(pypz) Ir(bmopbi)2(tfpypz) Ir(bmopbi)2(pytrz)Ir(bmopbi)2(pypz) Ir(bmopbi)2(tfpypz) Ir(bmopbi)2(pytrz)
Ir(bmmpbi)2(pypz) Ir(bmmpbi)2(tfpypz) Ir(bmmpbi)2(pytrz) 第49頁 200909438Ir(bmmpbi)2(pypz) Ir(bmmpbi)2(tfpypz) Ir(bmmpbi)2(pytrz) Page 49 200909438
第50頁 200909438Page 50 200909438
第51頁 200909438Page 51 200909438
Ir(ptmi)2(mptz)Ir(ptmi)2(mptz)
第52頁 200909438Page 52 200909438
Ir(ptmi)2(pytrz)Ir(ptmi)2(pytrz)
Ir(fptmi)2(tfptz)Ir(fptmi)2(tfptz)
Ir(fptmi)2(pytz)Ir(fptmi)2(pytz)
Ir(fptmi)2(tfpypz)Ir(fptmi)2(tfpypz)
Ir(fptmi)2(pytrz)Ir(fptmi)2(pytrz)
Ir(mmptmi)2(pytz) 第53頁 200909438Ir(mmptmi)2(pytz) Page 53 200909438
FF
FF
F FF F
Ir(mfptmi)2(pypz)Ir(mfptmi)2(pypz)
FF
MeOMeO
MeOMeO
Ir(momptmi)2(pytz) 第54頁 200909438Ir(momptmi)2(pytz) Page 54 200909438
MeOMeO
MeOMeO
MeOMeO
f \ lr(moniptmi)2(pypz)f \ lr(moniptmi)2(pypz)
Ir(momptmi)2(tfpypz)Ir(momptmi)2(tfpypz)
!r(mtfptmi)2(pytz)!r(mtfptmi)2(pytz)
Ir(mfptmi)2(tfpypz) Ir(mfptmi)2(pytrz)Ir(mfptmi)2(tfpypz) Ir(mfptmi)2(pytrz)
Ir(dmptmi)2(mptz) Ir(dmptmi)2(tfptz) Ir(dmptmi)2(pytz) 第55頁 f. 200909438Ir(dmptmi)2(mptz) Ir(dmptmi)2(tfptz) Ir(dmptmi)2(pytz) Page 55 f. 200909438
Ir(dmptmi)2(pytrz)Ir(dmptmi)2(pytrz)
Ir(dmptmi)2(pypz)Ir(dmptmi)2(pypz)
Ir(dfptmi)2(pypz) Ir(dfptmi)2(tfpypz) Ir(dfptmi)2(pytrz) %Ir(dfptmi)2(pypz) Ir(dfptmi)2(tfpypz) Ir(dfptmi)2(pytrz) %
第56頁 200909438Page 56 200909438
//
lr(dfptmi)2(mptz)Lr(dfptmi)2(mptz)
Ir(dmoptmi)2(pytr z)Ir(dmoptmi)2(pytr z)
Ir(ntmi)2(mptz) Ir(ntmi)2(tfptz) Ir(ntmi)2(pytz) 第57頁 200909438Ir(ntmi)2(mptz) Ir(ntmi)2(tfptz) Ir(ntmi)2(pytz) Page 57 200909438
Ir(ntmi)2(pytrz)Ir(ntmi)2(pytrz)
Ir(pntmi)2(pytz)Ir(pntmi)2(pytz)
Ir(pntmi)2(pytrz)Ir(pntmi)2(pytrz)
Ir(pytmi)2(pytz) 第58頁 200909438Ir(pytmi)2(pytz) Page 58 200909438
Ir(bmpdmi)2(tfptz) Ir(bmpdmi)2(mptz) Ir(bmpdmi)2(pytz) 第59頁 200909438Ir(bmpdmi)2(tfptz) Ir(bmpdmi)2(mptz) Ir(bmpdmi)2(pytz) Page 59 200909438
第60頁 200909438Page 60 200909438
Ir(bmmpdmi)2(pypz)Ir(bmmpdmi)2(pypz)
Ir(bmmpdmi)2(tfpypz)Ir(bmmpdmi)2(tfpypz)
Ir(bmmpdmi)2(pytrz)Ir(bmmpdmi)2(pytrz)
Ir(bmfpdmi)2(tfptz)Ir(bmfpdmi)2(tfptz)
第61頁 200909438Page 61 200909438
Ir(bmfpdmi)2(pypz)Ir(bmfpdmi)2(pypz)
ί.ί.
Ir(bmmopdmi)2(mptz) Ir(bimnopdini)^(tiptz) Ir(binmopdn]i)2(pytz) MeO MeO MeOIr(bmmopdmi)2(mptz) Ir(bimnopdini)^(tiptz) Ir(binmopdn]i)2(pytz) MeO MeO MeO
Ir(bmmopdmi)2(pypz) Ir(bmmopdmi)2(tfpypz) \Ir(bmmopdmi)2(pypz) Ir(bmmopdmi)2(tfpypz) \
Ir(bmtfpdmi)2(mptz) Ir(bmtfpdmi)2(tfptz)Ir(bmtfpdmi)2(mptz) Ir(bmtfpdmi)2(tfptz)
Ir(bmmopdim)2(pytrz)Ir(bmmopdim)2(pytrz)
第62頁 200909438 f3cPage 62 200909438 f3c
Ir(bmtfpdmi)2(pypz)Ir(bmtfpdmi)2(pypz)
第63頁 200909438Page 63 200909438
第64頁 200909438Page 64 200909438
第65頁 200909438Page 65 200909438
ff
VV
Ir(pmdpi)2(pypz)Ir(pmdpi)2(pypz)
ΛΛ
Ir(pmdpi)2(tfptz) Ir(pmdpi)2(pytz)Ir(pmdpi)2(tfptz) Ir(pmdpi)2(pytz)
第66頁 200909438Page 66 200909438
Ir(fpmdpi)2(mptz) Ir(fjpmdpi)2(tfptz)Ir(fpmdpi)2(mptz) Ir(fjpmdpi)2(tfptz)
Ir(fpmdpi)2(pytz)Ir(fpmdpi)2(pytz)
Ir(fpmdpi)2(pytrz)Ir(fpmdpi)2(pytrz)
Ir(mmpnidpi)2(pytz)Ir(mmpnidpi)2(pytz)
Ir(mmpmdpi)2(pytrz) 第67頁 200909438Ir(mmpmdpi)2(pytrz) Page 67 200909438
FF
FF
Ir(mfpmdpi)2(tfptz)Ir(mfpmdpi)2(tfptz)
FF
Ir(mfpmdpi)2(pypZ)Ir(mfpmdpi)2(pypZ)
FF
Ir(mfpmdpi)2(tfpypz)Ir(mfpmdpi)2(tfpypz)
Ir(mfpoidpi)2(pytrz)Ir(mfpoidpi)2(pytrz)
Ir(dmpmdpi)2(pypz)Ir(dmpmdpi)2(pypz)
Ir(dmpmdpi)2(tfpypz) Ir(dmpmdpi)2(pytr2) 第68頁 200909438Ir(dmpmdpi)2(tfpypz) Ir(dmpmdpi)2(pytr2) Page 68 200909438
Ir(dfpmdpi)2(mptz)Ir(dfpmdpi)2(mptz)
Ir(dfpmdpi)2(t^tz)Ir(dfpmdpi)2(t^tz)
Ir(dfpmdpi)2(pytz)Ir(dfpmdpi)2(pytz)
Ir(dfpmdpi)2(pypz)Ir(dfpmdpi)2(pypz)
Ir(dfpmdpi)2(tfpypz)Ir(dfpmdpi)2(tfpypz)
Ir(dfpmdpi)2(pytrz)Ir(dfpmdpi)2(pytrz)
Ir(dmoptmi)2(pypz)Ir(dmoptmi)2(pypz)
Ir(dmoptmi)2(tfpypz) Ir(dmoptmi)2(pytrz) 200909438Ir(dmoptmi)2(tfpypz) Ir(dmoptmi)2(pytrz) 200909438
Ir(dfptmi)2(mptz)Ir(dfptmi)2(mptz)
Ir(dfptmi)2(tfptz) Ir(dfptmi)2(pytz)Ir(dfptmi)2(tfptz) Ir(dfptmi)2(pytz)
Ir(nmdpi)2(mptz)Ir(nmdpi)2(mptz)
Ir(ntmdpi)2(tfptz)Ir(ntmdpi)2(tfptz)
200909438200909438
\_\_
Ir(pymdpi)2(pytz)Ir(pymdpi)2(pytz)
Ir(pymdpi)2(mptz) Ir(pymdpi)2(tfptz)Ir(pymdpi)2(mptz) Ir(pymdpi)2(tfptz)
Ir(pymdpi)2(pypz) Ir(pymdpi)2(tfpypz) Ir(pymdpi)2(pytrz) 第71頁 200909438Ir(pymdpi)2(pypz) Ir(pymdpi)2(tfpypz) Ir(pymdpi)2(pytrz) Page 71 200909438
Ir(bpdpi)2(mptz)Ir(bpdpi)2(mptz)
Ir(bpdpi)2(tfptz)Ir(bpdpi)2(tfptz)
Ir(bpdpi)2(pytrz)Ir(bpdpi)2(pytrz)
Ir(bmpdpi)2(mptz)Ir(bmpdpi)2(mptz)
第72頁 200909438Page 72 200909438
ff
第73頁 200909438 fPage 73 200909438 f
Ir(bmfpdpi)2(mptz)Ir(bmfpdpi)2(mptz)
Ir(bmfpdpi)2(pytz)Ir(bmfpdpi)2(pytz)
第74頁 200909438Page 74 200909438
\\
Ir(bmtfpdpi)2(pypz)Ir(bmtfpdpi)2(pypz)
Ir(bmt^»dpi)2(tfptz) f3cIr(bmt^»dpi)2(tfptz) f3c
Ir(bmtf^dpi)2(pytz)Ir(bmtf^dpi)2(pytz)
第75頁 200909438Page 75 200909438
ff
VV
第76頁 200909438Page 76 200909438
第77頁 200909438Page 77 200909438
於本實施例中,上述含有碳烯配位基的過渡金屬錯合物可用來 應用於有機電激發光(electroluminescence )元件與/或填光 (phosphorescence )元件中,特別是應用於有機電激發光元件與/ 或鱗光元件中的發光體材料、電子傳導材料(electronic transport material )、或是電洞傳導材料(hole transport material )。此外, 上述含有碳烯配位基的過渡金屬錯合物亦可應用於其他有機電子 第78頁 200909438 元件(organic electronic devices)之電子傳導材料(eiectronic transport material )、電洞傳導材料(hole transport material )。上 述之有機電子元件可以是有機太陽能電池、有機薄膜電晶體、有機 光導體、或是其他習知該項技藝者所熟悉之有機半導體元件。In the present embodiment, the above transition metal complex containing a carbene ligand can be used in an organic electroluminescence element and/or a phosphorescence element, particularly in organic electroluminescence. An illuminant material, an electronic transport material, or a hole transport material in the component and/or the squaring element. Further, the above transition metal complex containing a carbene ligand may also be applied to an eiectronic transport material or a hole transport material of other organic electrons, page 09200909438 (organic electronic devices). ). The organic electronic component described above may be an organic solar cell, an organic thin film transistor, an organic photoconductor, or other organic semiconductor component familiar to those skilled in the art.
Example 1.形成以銀金屬為中心之含有碳烯配位基的過渡金屬錯 合物的一般流程 合成銥金屬雙聚體之一般流程: 參考下列反應式,藉由化合物4與氯化銥反應可形成一銥金屬 雙聚體(化合物5)。Example 1. General procedure for forming a transition metal complex containing a carbene ligand centered on a silver metal. General procedure for synthesizing a ruthenium metal dimer: Refer to the following reaction formula, by reacting compound 4 with ruthenium chloride. A ruthenium metal dimer (compound 5) is formed.
R = H, F, Me 上述反應之大致步驟如后。首先,於一反應器中加入氧化銀 (Ag20)(926 mg,4mm〇le)。接著’分別加入上述之化合物4(1 22 g,4 mmole )以及含結晶水氯化銥(353 mg,lmm〇le ),並加入4如 乙二醇單乙醚作為溶劑。其次,利祕猪包覆上述之反應器,並將 其置入12〇 C的油浴鋼中反應小時。 接下來’於上述之第三反靡 - 久嫕裔中加入水將固體逼出並加以過 濾。接著’移除濾液並利用二翕田e + + m\ & 氣甲垸清洗固體,據此分離可溶的產 物和不溶的氧化銀。之後,谨於^ 辰务目;處液以得到一固體,並利用乙醇進 第79頁 200909438 行再結晶以得到上述之化合物5,其係為白灰色固體(2〇3mg)產 率為35 %。 ( 合成以銀金屬為中心之含有破烯配位基的過渡金屬錯合物的一般 流程:參考下列反應式,藉由化合物6分別與不同的化合物7、化合 物9以及化合物11進行反應,可分別形成形成不同型態之含有碳 烯配位基的過渡金屬錯合物(化合物8、10、12)。R = H, F, Me The general steps of the above reaction are as follows. First, silver oxide (Ag20) (926 mg, 4 mm〇le) was added to a reactor. Next, the above-mentioned compound 4 (1 22 g, 4 mmole) and hydrazine chloride (353 mg, lmm〇le) were added, respectively, and 4, such as ethylene glycol monoethyl ether, was added as a solvent. Secondly, the faint pigs were coated with the above reactor and placed in a 12 〇 C oil bath steel for reaction hours. Next, add water to the third ruminant-long-year-old scorpion to force the solids out and filter. The filtrate was then removed and the solid was washed with a second field of e + m m & gas, and the soluble product and the insoluble silver oxide were separated accordingly. After that, I will work on the liquid to obtain a solid, and recrystallize it by using ethanol to page 79, 200909438 to obtain the above compound 5, which is a white-gray solid (2〇3 mg) yield of 35%. . (General procedure for synthesizing a transition metal complex containing a olefinic ligand centered on a silver metal: by reacting the compound 6 with a different compound 7, compound 9, and compound 11, respectively, with reference to the following reaction formula, respectively Transition metal complexes (compounds 8, 10, 12) containing different carbene ligands are formed.
+ R3 HN、々N+ R3 HN, 々N
Et3N, 85 °C 2-ethoxyethanolEt3N, 85 °C 2-ethoxyethanol
R3 nK u 7a R3 = Me 7b R3 = CF, 8a R1 = Me, R2 = H, R3 = Me 8b R1 = Me, R2 = H, R3 = CF3 8c R1 = Me, R2 = F, R3 = Me 8d R1 = Me, R2 = F, R3 = CF3 8e R1 = Me, R2 = Me, R3 = Me 8f R1 = Me, R2 = Me, R3 = CF3 R2 R2R3 nK u 7a R3 = Me 7b R3 = CF, 8a R1 = Me, R2 = H, R3 = Me 8b R1 = Me, R2 = H, R3 = CF3 8c R1 = Me, R2 = F, R3 = Me 8d R1 = Me, R2 = F, R3 = CF3 8e R1 = Me, R2 = Me, R3 = Me 8f R1 = Me, R2 = Me, R3 = CF3 R2 R2
R2 +R2 +
9a R4 = H 9b R4 = CF3 10a R1 = Me, R2 = H, R4 = H 10b R1 = Me, R2 = H, R4 = CF3 10c R1 = Me, R2 = F, R4 = H lOd R1 = Me, R2 = F, R4 = CF3 lOe R1 = Me, R2 = Me, R4 = H lOf R1 = Me, R2 = Me, R4 = CF3 第80頁 200909438 R29a R4 = H 9b R4 = CF3 10a R1 = Me, R2 = H, R4 = H 10b R1 = Me, R2 = H, R4 = CF3 10c R1 = Me, R2 = F, R4 = H lOd R1 = Me, R2 = F, R4 = CF3 lOe R1 = Me, R2 = Me, R4 = H lOf R1 = Me, R2 = Me, R4 = CF3 Page 80 200909438 R2
12b R1 = Me, R2 = Η, X = N, Y = N 12c R1 = Me, R2 = F, X = N, Y = C 12d R1 = Me, R2 = F, X = N, Y = N 12e R1 = Me, R2 = Me, X = N, Y = C 12f R1 = Me, R2 = Me, X = N, Y = N12b R1 = Me, R2 = Η, X = N, Y = N 12c R1 = Me, R2 = F, X = N, Y = C 12d R1 = Me, R2 = F, X = N, Y = N 12e R1 = Me, R2 = Me, X = N, Y = C 12f R1 = Me, R2 = Me, X = N, Y = N
66
以下將以化合物9b為例說明上述之反應流程。首先,於一第 四反應器中分別加入上述之化合物6 ( 50 mg,0.0434 mmole),化 合物 9b (21 mg,0.0955 mmole)以及三乙基胺(14 mg,0.0955 mmole)。接著,加入2 ml乙二醇單乙醚作為溶劑,並將反應系 統置入120 °C油浴鋼中反應1〇小時,其中,反應過程中將有固體 慢慢析出。於反應完全後,直接過濾產物以除去溶液,並以甲醇清 洗所得固體。最後,利用乙醇進行再結晶程序即可以得到上述之化 合物10d(notl0b?!),其係為白色固體(43mg),產率約為71 %。The above reaction scheme will be described below by taking the compound 9b as an example. First, the above compound 6 (50 mg, 0.0434 mmole), compound 9b (21 mg, 0.0955 mmole) and triethylamine (14 mg, 0.0955 mmole) were separately added to a fourth reactor. Next, 2 ml of ethylene glycol monoethyl ether was added as a solvent, and the reaction system was placed in a 120 ° C oil bath steel for 1 hour, in which a solid was gradually precipitated during the reaction. After the reaction was completed, the product was directly filtered to remove the solution, and the obtained solid was washed with methanol. Finally, the above compound 10d (notl0b?!) was obtained as a white solid (43 mg) in a yield of about 71%.
Example 2.Example 2.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 ) (2-(5-Methyl-2H-l,2,4-triazol-3-yl)-pyridine) [以下簡稱 Ir(pmi)2(mptz)] 第81頁 200909438Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 ) (2-(5-Methyl-2H-l,2,4-triazol-3-yl)-pyridine) [hereinafter referred to as Ir(pmi)2(mptz)] Page 81 200909438
lH NMR (CD2C12, 400 MHz) 8.04 (d, 1H, CH-N), 7.94 (d, 1H), 7.73 (td, 1H), 7.45 (d, 1H), 7.43 (d, 1H), 7.13-7.11 (m, 2H), 6.96-6.89 (m, 3H), 6.85 (d, 2H), 6.71-6.63 (m, 2H), 6.53 (d, 1H), 6.43 (d, 1H), 3.09 (s, 3H), 2.99 (s, 3H) , 2.33 (s, 3H).lH NMR (CD2C12, 400 MHz) 8.04 (d, 1H, CH-N), 7.94 (d, 1H), 7.73 (td, 1H), 7.45 (d, 1H), 7.43 (d, 1H), 7.13-7.11 (m, 2H), 6.96-6.89 (m, 3H), 6.85 (d, 2H), 6.71-6.63 (m, 2H), 6.53 (d, 1H), 6.43 (d, 1H), 3.09 (s, 3H ), 2.99 (s, 3H), 2.33 (s, 3H).
Example 3.Example 3.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 ) (2-(5-Trifloromethyl-2J^-l,2,4-triazol-3-yI)-pyridine) [以下簡稱 Ir(pmi)2(tfptz)]Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 ) (2-(5-Trifloromethyl-2J^-l,2,4-triazol-3-yI)-pyridine) Referred to as Ir(pmi)2(tfptz)]
lU NMR (CD2C12, 400 MHz) 8.19 (d, 1H, CH-N), 7.96 (d, 1H), 7.75 (t, 1H), 7.39 (d, 2H), 7.08-7.02 (m, 2H), 6.91-6.78 (m, 5H), 6.70-6.61 (m, 2H), 6.48 (d, 1H), 6.39 (d, 1H), 3.08 (s, 3H), 2.95 (s, 3H).lU NMR (CD2C12, 400 MHz) 8.19 (d, 1H, CH-N), 7.96 (d, 1H), 7.75 (t, 1H), 7.39 (d, 2H), 7.08-7.02 (m, 2H), 6.91 -6.78 (m, 5H), 6.70-6.61 (m, 2H), 6.48 (d, 1H), 6.39 (d, 1H), 3.08 (s, 3H), 2.95 (s, 3H).
Example 4.Example 4.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 )(2-(2iy-Pyrazol-3-yl)-pyridine) 第82頁 200909438 [以下簡稱 Ir(pmi)2(pypz)]Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 )(2-(2iy-Pyrazol-3-yl)-pyridine) Page 82 200909438 [hereinafter referred to as Ir(pmi) 2 ( Pypz)]
TH NMR (CD2C12, 400 MHz) ^ 7.90-7.92 (m, 1H, CH-N), 7.59-7.68 (m, 2H), 7.46 (d, 1H), 7.42 (dd, 2H), 7.11 (td, 2H), 6.85-6.93 (m, 2H), 6.83 (d, 1H), 6.82 (d, 1H), 6.76-6.80 (m, 1H), 6.72 (d, 1H), 6.69 (td, 1H), 6.63 (td, 1H), 6.48 (d, 1H), 6.56 (dd, 1H), 6.45 (dd, 1H), 3.04 (s, 3H), 2.98 (s,3H); HRMS Calcd. for C28H24IrN7 651.1722,Found: 651.1725.TH NMR (CD2C12, 400 MHz) ^ 7.90-7.92 (m, 1H, CH-N), 7.59-7.68 (m, 2H), 7.46 (d, 1H), 7.42 (dd, 2H), 7.11 (td, 2H ), 6.85-6.93 (m, 2H), 6.83 (d, 1H), 6.82 (d, 1H), 6.76-6.80 (m, 1H), 6.72 (d, 1H), 6.69 (td, 1H), 6.63 ( Td, 1H), 6.48 (d, 1H), 6.56 (dd, 1H), 6.45 (dd, 1H), 3.04 (s, 3H), 2.98 (s, 3H); HRMS Calcd. for C28H24IrN7 651.1722, Found: 651.1725 .
Example 5.Example 5.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-yIidene-C,C2 )(2-(5-Trifluoromethyl-2iT-pyrazol-3-yl)-pyridine) [以下簡稱 Ir(pmi)2(tfpypz)]Iridium(III) bis(l-phenyl-3-methylimdazolin-2-yIidene-C,C2 )(2-(5-Trifluoromethyl-2iT-pyrazol-3-yl)-pyridine) [hereinafter referred to as Ir(pmi) 2 ( Tfpypz)]
!H NMR (CD2C12, 400 MHz) ^ 7.95-7.93 (m, 1H, CH-N), 7.72-7.65 (m, 2H), 7.47 (d, 1H), 7.42 (d, 2H), 7.13-7.10 (m, 2H), 6.98 (s, 1H), 6.82 (d, 1H), 6.94-6.85 (m, 5H), 6.71-6.64 (m, 2H), 6.50 (dd, 1H), 6.42 (dd, 1H), 3.01 (s, 3H), 3.00 (s, 3H); HRMS Calcd. for 第83頁 200909438 C29H23F3IrN7 719.1596, Found: 719.1592.!H NMR (CD2C12, 400 MHz) ^ 7.95-7.93 (m, 1H, CH-N), 7.72-7.65 (m, 2H), 7.47 (d, 1H), 7.42 (d, 2H), 7.13-7.10 ( m, 2H), 6.98 (s, 1H), 6.82 (d, 1H), 6.94-6.85 (m, 5H), 6.71-6.64 (m, 2H), 6.50 (dd, 1H), 6.42 (dd, 1H) , 3.01 (s, 3H), 3.00 (s, 3H); HRMS Calcd. for Page 83 200909438 C29H23F3IrN7 719.1596, Found: 719.1592.
Example 6.Example 6.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,(72’)(5-(pyridine-2-yl)-7£T-triazolate) [以下簡稱 Ir(pmi)2(pytz)]Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,(72')(5-(pyridine-2-yl)-7£T-triazolate) [hereinafter referred to as Ir(pmi)2 ( Pytz)]
\=J NMR (CD2C12, 400 MHz) 8.15 (s, 1H), 7.95-7.94 (m, 1H), 7.77-7.68 (m, 2H), 7.46 (d, 1H), 7.44 (d, 1H), 7.15-7.12 (m, 2H), 6.96-6.84 (m, 5H), 6.73-6.65 (m, 2H), 6.55 (dd, 1H), 6.47 (dd, 1H), 3.00 (s, 3H), 2.99 (s, 3H); HRMS Calcd. for C27H23IrN8 652.1675, Found: 652.1677.\=J NMR (CD2C12, 400 MHz) 8.15 (s, 1H), 7.95-7.94 (m, 1H), 7.77-7.68 (m, 2H), 7.46 (d, 1H), 7.44 (d, 1H), 7.15 -7.12 (m, 2H), 6.96-6.84 (m, 5H), 6.73-6.65 (m, 2H), 6.55 (dd, 1H), 6.47 (dd, 1H), 3.00 (s, 3H), 2.99 (s , 3H); HRMS Calcd. for C27H23IrN8 652.1675, Found: 652.1677.
Example 7.Example 7.
Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 )(2-(1H- tetrazol-5-yl)pyridine) [以下簡稱 Ir(pmi)2(pytrz)]Iridium(III) bis(l-phenyl-3-methylimdazolin-2-ylidene-C,C2 )(2-(1H-tetrazol-5-yl)pyridine) [hereinafter referred to as Ir(pmi)2(pytrz)]
NMR (CD2C12, 400 MHz) 8.33 (d, 1H), 8.02 (d, 1H), 7.86 (td, 第84頁 200909438 1H), 7.46 (d, 1H), 7.44 (d, 1H), 7.16-7.10 (m, 3H), 6.98-6.90 (m, 2H), 6.87 (d, 1H), 6.84 (d, 1H), 6.74-6.66 (m, 2H), 6.53 (dd, 1H), 6.45 (dd, 1H), 2.98 (s, 3H), 2.95 (s, 3H); HRMS Calcd. for C26H22IrN9 653.1627, Found: 653.1627.NMR (CD2C12, 400 MHz) 8.33 (d, 1H), 8.02 (d, 1H), 7.86 (td, page 84 200909438 1H), 7.46 (d, 1H), 7.44 (d, 1H), 7.16-7.10 ( m, 3H), 6.98-6.90 (m, 2H), 6.87 (d, 1H), 6.84 (d, 1H), 6.74-6.66 (m, 2H), 6.53 (dd, 1H), 6.45 (dd, 1H) , 2.98 (s, 3H), 2.95 (s, 3H); HRMS Calcd. for C26H22IrN9 653.1627, Found: 653.1627.
Example 8. Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazoIin-2-ylidene-C,C2>) Chloride Dimer [以下簡稱 Ir(fpmi)2 dimer]Example 8. Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazoIin-2-ylidene-C,C2>) Chloride Dimer [hereinafter referred to as Ir(fpmi)2 dimer]
NMR (CD2C12, 400 MHz) 7.56 (d, 4H), 7.19 (d, 4H), 6.96 (dd, 4H), 6.46 (td, 4H), 5.75 (dd, 4H), 3.87 (s, 12H)NMR (CD2C12, 400 MHz) 7.56 (d, 4H), 7.19 (d, 4H), 6.96 (dd, 4H), 6.46 (td, 4H), 5.75 (dd, 4H), 3.87 (s, 12H)
Example 9.Example 9.
Iridium(III) bis(l-(4-fluorophenyl)-3-raethylimdazolin-2-ylidene-C, C1 2 )(2-(5-Methyl-2H-l,2,4-triazol-3-yl)-pyridine) [以下簡稱 Ir(fpmi)2(mptz)]Iridium(III) bis(l-(4-fluorophenyl)-3-raethylimdazolin-2-ylidene-C, C1 2 )(2-(5-Methyl-2H-l,2,4-triazol-3-yl)- Pyridine) [hereinafter referred to as Ir(fpmi) 2 (mptz)]
NyN 1 B. NMR (CD2C12, 400 MHz) ^ 8.05 (d, 1H, CH-N), 7.93 (d, 1H), 2 第85頁 200909438 7.75 (td, 1H), 7.42 (d, 1H), 7.39 (d, 1H), 7.12-7.06 (m, 2H), 6.99-6.96 (m, 1H), 6.86 (d, 2H), 6.66-6.57 (m, 2H), 6.19 (dd, 1H), 6.08 (dd, 1H), 3.08 (s, 3H), 2.98 (s, 3H) , 2.33 (s, 3H).NyN 1 B. NMR (CD2C12, 400 MHz) ^ 8.05 (d, 1H, CH-N), 7.93 (d, 1H), 2 Page 85 200909438 7.75 (td, 1H), 7.42 (d, 1H), 7.39 (d, 1H), 7.12-7.06 (m, 2H), 6.99-6.96 (m, 1H), 6.86 (d, 2H), 6.66-6.57 (m, 2H), 6.19 (dd, 1H), 6.08 (dd , 1H), 3.08 (s, 3H), 2.98 (s, 3H), 2.33 (s, 3H).
Example 10.Example 10.
Iridium(III) bis(l-(4-fIuorophenyI)-3-methyIimdazolin-2-ylidene-C, C2 )(2-(5-Trifluoromethyl-2^-l,2,4-triazoI-3-yl)-pyridine) [以下簡稱 Ir(fpmi)2(tfptz)]Iridium(III) bis(l-(4-fIuorophenyI)-3-methyIimdazolin-2-ylidene-C, C2 )(2-(5-Trifluoromethyl-2^-l,2,4-triazoI-3-yl)- Pyridine) [hereinafter referred to as Ir(fpmi)2(tfptz)]
ιΉ. NMR (CD2C12, 400 MHz) 8.19-8.17 (m, 1H, CH-N), 7.99 (d, 1H), 7.84 (td, 1H), 7.44 (d, 2H), 7.41 (d, 2H), 7.13-7.09 (m, 3H), 6.88 (d, 2H), 6.68-6.56 (m, 2H), 6.17 (dd, 1H), 6.06 (dd, 1H), 3.04 (s, 3H), 2.97 (s, 3H).Ή ( NMR (CD2C12, 400 MHz) 8.19-8.17 (m, 1H, CH-N), 7.99 (d, 1H), 7.84 (td, 1H), 7.44 (d, 2H), 7.41 (d, 2H), 7.13-7.09 (m, 3H), 6.88 (d, 2H), 6.68-6.56 (m, 2H), 6.17 (dd, 1H), 6.06 (dd, 1H), 3.04 (s, 3H), 2.97 (s, 3H).
Example 11.Example 11.
Iridium(III) bis(l-(4-f!uorophenyl)-3-methylimdazolin-2-ylidene-C, C2 )(2-(2^-Pyrazol-3-yl)-pyridine)[以下簡稱 Ir(fpmi)2(pypz)]Iridium(III) bis(l-(4-f!uorophenyl)-3-methylimdazolin-2-ylidene-C, C2 )(2-(2^-Pyrazol-3-yl)-pyridine) [hereinafter referred to as Ir(fpmi) )2(pypz)]
\=y H NMR (CD2C12, 400 MHz) 7.90 (dd, 1H, CH-N), 7.68-7.61 (m, 第86頁 200909438 2H), 7.47 (d, 1H), 7.40 (dd, 2H), 7.11-7.04 (m, 2H), 6.85-6.79 (m, 3H), 6.71 (d, 1H), 6.64-6.54 (m, 2H), 6.23 (dd, 1H), 6.09 (dd, 1H), 3.03 (s,3H),2.97 (s, 3H); HRMS Calcd. for C28H24F2IrN7 689.1690, Found: 689.1687.\=y H NMR (CD2C12, 400 MHz) 7.90 (dd, 1H, CH-N), 7.68-7.61 (m, page 86 200909438 2H), 7.47 (d, 1H), 7.40 (dd, 2H), 7.11 -7.04 (m, 2H), 6.85-6.79 (m, 3H), 6.71 (d, 1H), 6.64-6.54 (m, 2H), 6.23 (dd, 1H), 6.09 (dd, 1H), 3.03 (s , 3H), 2.97 (s, 3H); HRMS Calcd. for C28H24F2IrN7 689.1690, Found: 689.1687.
Example 12.Example 12.
Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazolin-2-ylidene-C, C2 )(2-(5-Trifluoromethyl-2^-pyrazol-3-yl)-pyridine) [以下簡稱 Ir(fpmi)2(tfpypz)]Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazolin-2-ylidene-C, C2 )(2-(5-Trifluoromethyl-2^-pyrazol-3-yl)-pyridine) [hereinafter referred to as Ir (fpmi)2(tfpypz)]
lH NMR (CD2C12, 400 MHz) ^ 7.93 (d, 1H, CH-N), 7.71-7.69 (m, 2H), 7.43 (d, 1H), 7.39 (dd, 2H), 7.11-7.07 (m, 2H), 6.98 (s, 1H), 6.92-6.90 (m, 1H), 6.89-6.85 (m, 2H), 6.63-6.59 (m, 2H), 6.16 (dd, 1H), 6.06 (dd, 1H), 3.00 (s, 3H), 2.99 (s, 3H); HRMS Calcd. for C29H2iF5IrN7 755.1408, Found: 755.1406.lH NMR (CD2C12, 400 MHz) ^ 7.93 (d, 1H, CH-N), 7.71-7.69 (m, 2H), 7.43 (d, 1H), 7.39 (dd, 2H), 7.11-7.07 (m, 2H ), 6.98 (s, 1H), 6.92-6.90 (m, 1H), 6.89-6.85 (m, 2H), 6.63-6.59 (m, 2H), 6.16 (dd, 1H), 6.06 (dd, 1H), 3.00 (s, 3H), 2.99 (s, 3H); HRMS Calcd. for C29H2iF5IrN7 755.1408, Found: 755.1406.
Example 13.Example 13.
Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazolin-2-ylidene-C, C2') (5-(pyridine-2-yl)-2^-triazolate)[以下簡稱 Ir(fpmi)2(pytz)] 第87頁 200909438Iridium(III) bis(l-(4-fluorophenyl)-3-methylimdazolin-2-ylidene-C, C2') (5-(pyridine-2-yl)-2^-triazolate) [hereinafter referred to as Ir(fpmi) 2(pytz)] Page 87 200909438
NMR (CD2C12, 400 MHz) 8.15 (s, 1H), 7.94-7.92 (m, 1H), 7.77-7.69 (m, 2H), 7.43 (d, 1H), 7.40 (d, 1H), 7.13-7.07 (m, 2H), 6.93-6.90 (m, 1H), 6.86 (d, 1H), 6.85 (d, 1H), 6.67-6.58 (m, 2H), 6.22 (dd, 1H), 6.11 (dd, 1H), 2.99 (s, 3H), 2.98 (s, 3H); HRMS Calcd. for C27H2iF2IrN8 688.1486, Found: 688.1486.NMR (CD2C12, 400 MHz) 8.15 (s, 1H), 7.94-7.92 (m, 1H), 7.77-7.69 (m, 2H), 7.43 (d, 1H), 7.40 (d, 1H), 7.13-7.07 ( m, 2H), 6.93-6.90 (m, 1H), 6.86 (d, 1H), 6.85 (d, 1H), 6.67-6.58 (m, 2H), 6.22 (dd, 1H), 6.11 (dd, 1H) , 2.99 (s, 3H), 2.98 (s, 3H); HRMS Calcd. for C27H2iF2IrN8 688.1486, Found: 688.1486.
Example 14.Example 14.
Iridium(III) bis(l-(4-fIuorophenyl)-3-methylimdazolin-2-yIidene-C, C2 ) (2-(2^-tetrazol-5-yl)pyridine) [以下簡稱 Ir(fpmi)2(pytrz)]Iridium(III) bis(l-(4-fIuorophenyl)-3-methylimdazolin-2-yIidene-C, C2 ) (2-(2^-tetrazol-5-yl)pyridine) [hereinafter referred to as Ir(fpmi) 2 ( Pytrz)]
\=f lH NMR (CD2C12, 400 MHz) ^ 8.35-8.33 (m, 1H), 8.03-8.01 (m, 1H), 7.89 (td, 1H), 7.43 (d, 1H), 7.42 (d, 1H), 7.18-7.09 (m, 3H), 6.88 (d, 1H), 6.85 (d, 1H), 6.69-6.60 (m, 2H), 6.20 (dd, 1H), 6.09 (dd, 1H), 2_97 (s,3H), 2.94 (s,3H); HRMS Calcd. for C26H20F2IrN9 689.1439, Found: 689.1441. 第88頁 200909438\=f lH NMR (CD2C12, 400 MHz) ^ 8.35-8.33 (m, 1H), 8.03-8.01 (m, 1H), 7.89 (td, 1H), 7.43 (d, 1H), 7.42 (d, 1H) , 7.18-7.09 (m, 3H), 6.88 (d, 1H), 6.85 (d, 1H), 6.69-6.60 (m, 2H), 6.20 (dd, 1H), 6.09 (dd, 1H), 2_97 (s ,3H), 2.94 (s,3H); HRMS Calcd. for C26H20F2IrN9 689.1439, Found: 689.1441. Page 88 200909438
Example 15. Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-ylidene C,C2) Chloride Dimer [以下簡稱 Ir(mpmi)2 dimer]Example 15. Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-ylidene C,C2) Chloride Dimer [hereinafter referred to as Ir(mpmi)2 dimer]
Ή NMR (CD2C12, 400 MHz) ^ 7.47 (d, 4H), 7.05 (d, 4H), 6.77 (d, 4H), 6.42 (dd, 4H), 5.96 (s, 4H), 3.84 (s, 12H), 1.95 (s, 12H)NMR NMR (CD2C12, 400 MHz) ^ 7.47 (d, 4H), 7.05 (d, 4H), 6.77 (d, 4H), 6.42 (dd, 4H), 5.96 (s, 4H), 3.84 (s, 12H) , 1.95 (s, 12H)
Example 16.Example 16.
Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-yIidene-C,C2,)(2-(5-Methyl-2flr-l,2,4-triazol-3-yl)-pyridine) [以下簡稱 Ir(mpmi)2(mptz)]Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-yIidene-C,C2,)(2-(5-Methyl-2flr-l,2,4-triazol-3-yl)- Pyridine) [hereinafter referred to as Ir(mpmi)2(mptz)]
!H NMR (CD2C12, 400 MHz) 8.02 (d, 1H, CH-N), 7.96 (d, 1H), 7.72 (td, 1H), 7.42 (d, 1H), 7.39 (d, 1H), 7.02 (d, 1H), 7.00 (d, 1H), 6.96-6.93 (m, 1H), 6.83 (d, 2H), 6.74-6.69 (m, 2H), 6.30 (d, 1H), 6.20 (d, 1H), 3.08 (s, 3H), 2.97 (s, 3H) , 2.33 (s, 3H), 2.14 (s, 3H), 2.13 (s, 3H). 第89頁 200909438!H NMR (CD2C12, 400 MHz) 8.02 (d, 1H, CH-N), 7.96 (d, 1H), 7.72 (td, 1H), 7.42 (d, 1H), 7.39 (d, 1H), 7.02 ( d, 1H), 7.00 (d, 1H), 6.96-6.93 (m, 1H), 6.83 (d, 2H), 6.74-6.69 (m, 2H), 6.30 (d, 1H), 6.20 (d, 1H) , 3.08 (s, 3H), 2.97 (s, 3H), 2.33 (s, 3H), 2.14 (s, 3H), 2.13 (s, 3H). Page 89 200909438
Example 17.Example 17.
Iridium(III) bis(l-(4-methylphenyI)-3-methylimdazoIin-2-ylidene-C,C2,)(2-(5-Trifluoro methyl1,2,4-triazol-3-yl)-pyridine) [以下簡稱 Ir(mpmi)2(tfptz)]Iridium(III)bis (1-(5-Trifluoromethyl1,2,4-triazol-3-yl)-pyridine) Hereinafter referred to as Ir(mpmi)2(tfptz)]
^ NMR (CD2C12, 400 MHz) 8.16 (d, 1H, CH-N), 8.02 (d, 1H), 7.80 (td, 1H), 7.44 (d, 1H), 7.40 (d, 1H), 7.09-7.02 (m, 3H), 6.86-6.85 (m, 2H), 6.76-6.72 (m, 2H), 6.28 (s, 1H), 6.19 (s, 1H), 3.04 (s, 3H), 2.96 (s, 3H) , 2.15 (s, 3H), 2.14 (s, 3H).^ NMR (CD2C12, 400 MHz) 8.16 (d, 1H, CH-N), 8.02 (d, 1H), 7.80 (td, 1H), 7.44 (d, 1H), 7.40 (d, 1H), 7.09-7.02 (m, 3H), 6.86-6.85 (m, 2H), 6.76-6.72 (m, 2H), 6.28 (s, 1H), 6.19 (s, 1H), 3.04 (s, 3H), 2.96 (s, 3H) ), 2.15 (s, 3H), 2.14 (s, 3H).
Example 18.Example 18.
Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-ylidene-C,C2 )(2-(2£T-Pyrazol-3-yl)-pyridine) [以下簡稱 Ir(mpmi)2(pypz)]Iridium(III) bis(l-(4-methylphenyl)-3-methylimdazolin-2-ylidene-C,C2 )(2-(2£T-Pyrazol-3-yl)-pyridine) [hereinafter referred to as Ir(mpmi) 2(pypz)]
'H NMR (CD2C12, 400 MHz) ^ 7.93 (d, 1H, CH-N), 7.67-7.59 (m, 2H), 7.45 (d, 1H), 7.40 (d, 1H), 7.39 (d, 1H), 7.01 (d, 2H), 7.00 (d, 第90頁 200909438 2H), 6.82-6.77 (m, 3H), 6.73-6.68 (m, 2H), 6.71 (d, 2H), 6.35 (s, 1H), 6.22 (s, 1H), 3.01 (s, 3H), 2.97 (s, 3H) , 2.15 (s, 3H), 2.13 (s, 3H).'H NMR (CD2C12, 400 MHz) ^ 7.93 (d, 1H, CH-N), 7.67-7.59 (m, 2H), 7.45 (d, 1H), 7.40 (d, 1H), 7.39 (d, 1H) , 7.01 (d, 2H), 7.00 (d, page 90 200909438 2H), 6.82-6.77 (m, 3H), 6.73-6.68 (m, 2H), 6.71 (d, 2H), 6.35 (s, 1H) , 6.22 (s, 1H), 3.01 (s, 3H), 2.97 (s, 3H), 2.15 (s, 3H), 2.13 (s, 3H).
Example 19.Example 19.
Iridium(III) bis(l-(4-methylphenyI)-3-methylimdazolin-2-ylidene-C,C2 )(2-(5-Trifluoromethyl-2^-pyrazol-3-yl)-pyridine) [以下簡稱 Ir(mpmi)2(tfpypz)]Iridium(III) bis(l-(4-methylphenyI)-3-methylimdazolin-2-ylidene-C,C2 )(2-(5-Trifluoromethyl-2^-pyrazol-3-yl)-pyridine) [hereinafter referred to as Ir (mpmi)2(tfpypz)]
!H NMR (CD2C12, 400 MHz) ^ 7.96 (d, 1H, CH-N), 7.70-7.64 (m, 2H), 7.43 (d, 1H), 7.39 (d, 1H), 7.02 (d, 2H), 7.00 (d, 2H), 6.96 (s, 1H), 6.90-6.86 (m, 1H), 6.83 (d, 2H), 6.74-6.70 (m, 2H), 6.28 (s, 1H), 6.19 (s, 1H), 2.99 (s, 3H), 2.98 (s, 3H) , 2.15 (s, 3H), 2.14 (s, 3H).!H NMR (CD2C12, 400 MHz) ^ 7.96 (d, 1H, CH-N), 7.70-7.64 (m, 2H), 7.43 (d, 1H), 7.39 (d, 1H), 7.02 (d, 2H) , 7.00 (d, 2H), 6.96 (s, 1H), 6.90-6.86 (m, 1H), 6.83 (d, 2H), 6.74-6.70 (m, 2H), 6.28 (s, 1H), 6.19 (s , 1H), 2.99 (s, 3H), 2.98 (s, 3H), 2.15 (s, 3H), 2.14 (s, 3H).
Example 20.Example 20.
Iridium(III) bis(l-(4-methyl phe nyl)-3-me thylimdazolin-2-ylidene- C*,C2 ) (5-(pyridine-2-yl)-/丑-triazolate) [以下簡稱 Ir(mpmi)2(pytz)]Iridium(III) bis(l-(4-methyl phe nyl)-3-me thylimdazolin-2-ylidene- C*,C2 ) (5-(pyridine-2-yl)-/ ugly-triazolate) [hereinafter referred to as Ir (mpmi)2(pytz)]
第91頁 200909438 lH NMR (CD2C12, 400 MHz) ^ 8.14 (s, 1H), 7.95 (d, 1H), 7.75-7.66 (m, 2H), 7.43 (d, 1H), 7.40 (d, 1H), 7.03 (d, 1H), 7.01 (d, 1H), 6.90-6.87 (m, 1H), 6.84-6.82 (m, 2H), 6.74-6.70 (m, 2H), 6.32 (s, 1H), 6.23 (s, 1H), 2.99 (s, 3H), 2.97 (s, 3H), 2.15 (s, 3H), 2.14 (s, 3H).Page 91 200909438 lH NMR (CD2C12, 400 MHz) ^ 8.14 (s, 1H), 7.95 (d, 1H), 7.75-7.66 (m, 2H), 7.43 (d, 1H), 7.40 (d, 1H), 7.03 (d, 1H), 7.01 (d, 1H), 6.90-6.87 (m, 1H), 6.84-6.82 (m, 2H), 6.74-6.70 (m, 2H), 6.32 (s, 1H), 6.23 ( s, 1H), 2.99 (s, 3H), 2.97 (s, 3H), 2.15 (s, 3H), 2.14 (s, 3H).
Example 21.Example 21.
Iridium(III) bis(l-(4-methylphenyl)-3-methyIimdazoIin-2-yIidene-C,C2 )(2-(2^-tetrazol-5-yl)pyridine) [以下簡稱 Ir(mpmi)2(pytrz)]Iridium(III) bis(l-(4-methylphenyl)-3-methyIimdazoIin-2-yIidene-C,C2 )(2-(2^-tetrazol-5-yl)pyridine) [hereinafter referred to as Ir(mpmi)2( Pytrz)]
H NMR (CD2C12, 400 MHz) 8.32 (d, 1H), 8.03 (d, 1H), 7.85 (td, 1H), 7.43 (d, 1H), 7.41 (d, 1H), 7.14-7.11 (m, 1H), 7.05 (d, 1H), 7.03 (d, 1H), 6.84 (d, 1H), 6.82 (d, 1H), 6.77-6.72 (m, 2H), 6.30 (d, 1H),H NMR (CD2C12, 400 MHz) 8.32 (d, 1H), 8.03 (d, 1H), 7.85 (td, 1H), 7.43 (d, 1H), 7.41 (d, 1H), 7.14-7.11 (m, 1H ), 7.05 (d, 1H), 7.03 (d, 1H), 6.84 (d, 1H), 6.82 (d, 1H), 6.77-6.72 (m, 2H), 6.30 (d, 1H),
本發明之第二實施例揭露—電激發光(A⑽。iumi職元A second embodiment of the present invention discloses an electric excitation light (A(10).iumi job element
包含一含有碳烯配位基的過渡金屬錯合物,上述含Containing a transition metal complex containing a carbene ligand, the above
如下: 第92頁 200909438As follows: Page 92 200909438
其中,Μ係為一過渡金屬且係選自下列族_群之一者:釕 (ruthenium)、錢(rhodium)、鎢(tungsten)、銶(rhenium)、锇(osmium)、 銥(iridium)、翻(platinum)。R1係選自下列族群之一者:C1-C20烧 基、C1-C20環烷基、共軛芳香環基團(aromatic group)、雜芳香 雜環基團。R2 ~ R7可以相同或不同,且R2 ~ R7係獨立選自下列族 群之一者:氫原子(H)、鹵素原子(例如:氟、氣、溴、碘)、C1-C20 烧基(alkyl group) ' C1-C20 環烧基、炫氧基(alkoxyl group)、鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20 醯胺基(amide group) '芳香基、鹵素取代的芳香基、鹵素取代的芳香烧基、鹵烧 基取代的芳香基、鹵烷基取代的芳香烧基、氰基(cyan〇)、硝基 (nitro)、共軛芳香環基團(aromatic group)、芳香雜環基團。 在根據本實施例之一較佳範例中,上述含有碳烯配位基的過渡 金屬錯合物原子團中相鄰之R2與R3、r4與R5、R5與R6、R6與R7 等亦可以分別是形成一芳香環、芳香雜環、環烯基或是雜環烯基之 任意原子團。上述r2~R中未成%之取代基可以相同或不同,且 上述R2〜R7中未成環之取代基係獨立選自下列族群之一者:氫原 第93頁 200909438 子(Η)、鹵素原子、C1-C20烷基(alkyl group)、C1-C20環烷基、烷 氧基(alkoxyl group)、鹵素取代的C1-C20烷基、C1-C20取代的胺 基(amino group)、C1-C20 醯基(acyl group)、C1-C20 S旨基(ester group)、C1-C20醯胺基(amide group)、芳香基、鹵素取代的芳香基、 素取代的芳香烷基、鹵烷基取代的芳香基、_烷基取代的芳香烷 基、氰基(cyano)、硝基(nitro)、共輛芳香環基團(aromatic group )、 芳香雜環基團。 r 上述的芳香環、芳香雜環、環烯基或是雜環烯基等可以分別是 五元環、六元環、或是七元環,且上述之芳香環、芳香雜環 '環烯 基或是雜環烯基等可以更包含一個或多個取代基。上述之取代基可 以相同或不同,且上述取代基係獨立選自下列族群中之一者:氫原 子、鹵素原子(例如:襄、氯、溴、破);芳香基、鹵素取代的芳 香基、鹵素取代的芳香烷基、齒烷基取代的芳香基、鹵烷基取代的 芳香炫基、芳香基取代的C1-C20烧基;供電子基(electron donating group)如C1-C20烷基、C1-C20環烷基(例如:曱基、乙基、丁 基、環己基)、C1-C20炫氧基(alkoxy group) ' C1-C20取代的胺基 (amino group)、具有取代基的芳香胺基[例如苯胺基(aniline)]; 拉電子基(electron withdrawing group)如鹵素、亞石肖酸基(nitrile)、 硝基(nitro)、幾基(carbonyl)、氰基(cyano,-CN)與鹵素取代的 C1-C20烷基(例如三氟曱烷基,CF3);雜環取代基團。 在根據本實施例之另一較佳範例中,上述含有碳烯配位基的過 第94頁 200909438 渡金屬錯合物之結構如下:Wherein, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium, tungsten, rhenium, osmium, iridium, Platinum. R1 is selected from one of the following groups: a C1-C20 alkyl group, a C1-C20 cycloalkyl group, a conjugated aromatic ring group, a heteroaromatic heterocyclic group. R2 ~ R7 may be the same or different, and R2 ~ R7 are independently selected from one of the following groups: hydrogen atom (H), halogen atom (for example: fluorine, gas, bromine, iodine), C1-C20 alkyl group (alkyl group) ) 'C1-C20 cycloalkyl, alkoxyl group, halogen-substituted C1-C20 alkyl, C1-C20 substituted amino group, C1-C20 acyl group, C1- C20 ester group, C1-C20 amide group 'aryl group, halogen-substituted aromatic group, halogen-substituted aromatic alkyl group, halogen-substituted aromatic group, haloalkyl-substituted aromatic burning a group, a cyan group, a nitro group, a conjugated aromatic ring group, an aromatic heterocyclic group. In a preferred embodiment of the present embodiment, the adjacent R2 and R3, r4 and R5, R5 and R6, R6 and R7, etc. of the transition metal complex containing a carbene ligand may also be Any atomic group forming an aromatic ring, an aromatic heterocyclic ring, a cycloalkenyl group or a heterocycloalkenyl group. The substituents which are not % in the above r2 to R may be the same or different, and the unsubstituted substituents in the above R2 to R7 are independently selected from one of the following groups: hydrogenogen, page 93, 200909438, (halogen), halogen atom, C1-C20 alkyl group, C1-C20 cycloalkyl group, alkoxyl group, halogen-substituted C1-C20 alkyl group, C1-C20 substituted amino group, C1-C20 醯Acyl group, C1-C20 S ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, substituted aryl group, haloalkyl substituted aromatic a group, an alkyl-substituted arylalkyl group, a cyano group, a nitro group, a total aromatic group, and an aromatic heterocyclic group. r The above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above aromatic ring or aromatic heterocyclic ring-alkenyl group Or a heterocycloalkenyl group or the like may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example: hydrazine, chlorine, bromine, broken); an aryl group, a halogen-substituted aryl group, Halogen-substituted arylalkyl, dentate-substituted aryl, haloalkyl-substituted aryl, aryl-substituted C1-C20 alkyl; electron donating group such as C1-C20 alkyl, C1 -C20 cycloalkyl (eg, decyl, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group 'C1-C20 substituted amino group, aromatic amine with substituent a group [eg, an aniline]; an electron withdrawing group such as a halogen, a nitrile, a nitro group, a carbonyl group, or a cyano group (CNano). a C1-C20 alkyl group substituted with a halogen (e.g., trifluoroalkyl, CF3); a heterocyclic substituent. In another preferred embodiment according to this embodiment, the structure of the above-mentioned carbene-containing ligand, page 94, 200909438, is as follows:
其中,Μ係為一過渡金屬且係選自下列族群之一者:釕 (ruthenium)、鍵(rhodium)、鶴(tungsten)、銖(rhenium)、餓(osmium)、 銥(iridium)、鉑(platinum)。R1係選自下列族群之一者:C1-C20烷 基、C1-C20環烧基、共輛芳香環基團(aromatic group)、雜芳香 雜環基團。R2〜R7可以相同或不同,且R2 ~ R7係獨立選自下列族 群之一者:氫原子(H)、鹵素原子(例如:氟、氣、溴、碘)' CVCm 烧基(alkyl group)、C1-C20 環院基、烧氧基(alkoxyl group) ' 鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 醋基(ester group)、C1-C20 醯胺基(amide group)、芳香基、鹵素取代的芳香基、鹵素取代的芳香烷基、鹵烷 基取代的芳香基、鹵烷基取代的芳香烷基、氰基(cyano)、硝基 (nitro)、共輛芳香環基團(aromaticgroup)、芳香雜環基團。 根據本範例之一較佳實施方式,上述相鄰之R2與R3、R4與 R5、R5與R6、R6與R7等亦可以分別是形成一芳香環、芳香雜環、 環烯基或是雜環烯基之任意原子團。上述的芳香環、芳香雜環、環 _基或是雜環稀基可以分別是五元環、六元環、或是七元環,且上 第95頁 200909438 述芳香環、芳香雜環、環稀基或是雜環烯基可以更包含一個或多個 取代基。 上述R2〜R7中未成環之取代基可以相同或不同,且上述R2~ r7中未成環之取代基係獨立選自下列族群之一者:氫原子(Η)、鹵 素原子、C1-C20 统基(alkyl group)、C1-C20 3衣烧基、烧氧基(alkoxyl group)、鹵素取代的C1-C20烷基、C1-C20取代的胺基(amino gr〇up)、Cl-C20 醯基(acyl group)、Cl-C20 酯基(ester group)、Cl-C20 f 酸胺基(amide group)、 芳香基、鹵素取代的芳香基、鹵素取代的芳 香燒基、鹵烷基取代的芳香基'鹵燒基取代的芳香烧基、氰基 (cyano)、硝基(nitro) '共軛芳香環基團(ar〇matic group )、芳香雜 環基團。 根據本範例,上述結構中的Z1可以是用於構成含氮雜芳香環 或是含氮雜環烯基之任意原子團。上述之含氮雜芳香環或是含氮雜 ' 環烯基可以是五元環、六元環、或是七元環,且上述的Z1可以更 \ 包含一個或多個取代基。上述之取代基可以相同或不同,且上述取 代基係獨立選自下列族群中之一者:氫原子、鹵素原子(例如:歡、 氯、溴、碘);芳香基 '鹵素取代的芳香基、鹵素取代的芳香烷基、 鹵烷基取代的芳香基、ifi烷基取代的芳香烷基、芳香基取代的 C1-C20 院基;供電子基(electron donating group)如 C1-C20 烧 基、C1-C20環烷基(例如··曱基、乙基、丁基、環己基)、C1-C20 垸氧基(alkoxy group)、C1-C20取代的胺基(amino group)、具有取 第96頁 200909438 代基的芳香胺基[例如笨胺基(aniline)];拉電子基(electron withdrawing group)如鹵素、亞硝酸基(nitrile)、硝基(nitro)、羰基 (carbonyl)、氰基(cyano,-CN)與鹵素取代的C1-C20烧基(例如 三氟曱烷基,CF3);雜環取代基團。 在根據本範例之結構中,Y可以是選自下列族群之一者:氮 (N)、碳(C)、氧(〇)、硫(S)等原子,且Y可以更包含一取代基。Q 係為一至少包含二個原子之原子團,以構成一含氮雜環基團 (heterocyclic ring)。其中Q所包含之原子組合係選自下列族群: 氮、碳、氧、硫。上述的含氮雜環基團可以更包含一個或多個取代 基。上述之取代基可以相同或不同,且上述取代基係獨立選自下列 族群中之一者:氫原子、鹵素原子(例如:氟、氯、溴 '碘);芳 香基、鹵素取代的芳香基、鹵素取代的芳香院基、鹵烧基取代的芳 香基、鹵烷基取代的芳香烷基、芳香基取代的C1-C20烷基;供電 子基(electron donating group)如 C1-C20 烧基、C1-C20 環烧基 (例如:甲基、乙基、丁基、環己基)、C1-C20烷氧基(alkoxygroup)、 Cl-C20取代的胺基(amino group)、具有取代基的芳香胺基[例如 苯胺基(aniline)];拉電子基(electron withdrawing group)如鹵素、 亞硝酸基(nitrile)、硝基(nitro)、幾基(carbonyl )、氰基(cyano,-CN) 與鹵素取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取代基 團。 在根據本實施例之另一較佳範例中,上述含有端_烯配位基的過 第97頁 200909438 渡金屬錯合物之結構如下:Among them, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium, tungsten, rhenium, osmium, iridium, platinum ( Platinum). R1 is selected from one of the group consisting of C1-C20 alkyl, C1-C20 cycloalkyl, aromatic aromatic groups, heteroaromatic heterocyclic groups. R2 to R7 may be the same or different, and R2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom (for example, fluorine, gas, bromine, iodine) 'CVCm alkyl group, C1-C20 ring-based, alkoxyl group 'halogen-substituted C1-C20 alkyl, C1-C20 substituted amino group, C1-C20 acyl group, C1-C20 vinegar Ester group, C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted aryl group, haloalkyl-substituted aryl group, haloalkyl-substituted aryl group, Cyano, nitro, aromatic aromatic groups, aromatic heterocyclic groups. According to a preferred embodiment of the present invention, the adjacent R 2 and R 3 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 and the like may also form an aromatic ring, an aromatic heterocyclic ring, a cycloalkenyl group or a heterocyclic ring, respectively. Any atomic group of an alkenyl group. The above aromatic ring, aromatic heterocyclic ring, cyclo-yl group or heterocyclic ring group may be a five-membered ring, a six-membered ring or a seven-membered ring, respectively, and the above-mentioned aromatic ring, aromatic heterocyclic ring, ring on page 95, 200909438 The dilute or heterocycloalkenyl group may further comprise one or more substituents. The unsubstituted substituents in the above R2 to R7 may be the same or different, and the unsubstituted substituents in the above R2 to r7 are independently selected from one of the following groups: a hydrogen atom (Η), a halogen atom, and a C1-C20 system. (alkyl group), C1-C20 3 alkyl group, alkoxyl group, halogen-substituted C1-C20 alkyl group, C1-C20 substituted amino group (amino gr〇up), Cl-C20 fluorenyl group ( Acyl group), Cl-C20 ester group, Cl-C20 f amide group, aryl group, halogen-substituted aryl group, halogen-substituted aromatic alkyl group, haloalkyl-substituted aryl group a halogen-substituted aromatic alkyl group, a cyano group, a nitro group conjugated aromatic ring group (ar〇matic group), an aromatic heterocyclic group. According to the present example, Z1 in the above structure may be any atomic group for constituting the nitrogen-containing heteroaromatic ring or the nitrogen-containing heterocycloalkenyl group. The above nitrogen-containing heteroaromatic ring or nitrogen-containing heterocycloalkenyl may be a five-membered ring, a six-membered ring or a seven-membered ring, and the above Z1 may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, Huan, chlorine, bromine, iodine); an aromatic 'halogen-substituted aromatic group, Halogen-substituted arylalkyl, haloalkyl-substituted aryl, ifi-substituted arylalkyl, aryl-substituted C1-C20-based; electron donating group such as C1-C20 alkyl, C1 -C20 cycloalkyl (e.g., thiol, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group, C1-C20 substituted amino group, having a page 96 200909438 Aromatic amine group of the base [such as aniline]; electron withdrawing group such as halogen, nitrile, nitro, carbonyl, cyano , -CN) a C1-C20 alkyl group substituted with a halogen (for example, a trifluoroalkyl group, CF3); a heterocyclic substituent group. In the structure according to the present example, Y may be one selected from the group consisting of nitrogen (N), carbon (C), oxygen (oxime), sulfur (S), and the like, and Y may further contain a substituent. Q is an atomic group containing at least two atoms to constitute a nitrogen-containing heterocyclic ring. The atomic combination contained in Q is selected from the group consisting of nitrogen, carbon, oxygen, and sulfur. The above nitrogen-containing heterocyclic group may further contain one or more substituents. The above substituents may be the same or different, and the above substituents are independently selected from one of the following groups: a hydrogen atom, a halogen atom (for example, fluorine, chlorine, bromine 'iodine); an aromatic group, a halogen-substituted aromatic group, Halogen-substituted aroma-based, halogen-substituted aryl, haloalkyl-substituted arylalkyl, aryl-substituted C1-C20 alkyl; electron donating group such as C1-C20 alkyl, C1 -C20 cycloalkyl (for example: methyl, ethyl, butyl, cyclohexyl), C1-C20 alkoxy group, Cl-C20 substituted amino group, substituted aromatic amine group [eg aniline]; electron withdrawing group such as halogen, nitrile, nitro, carbonyl, cyano (-CN) and halogen C1-C20 alkyl (e.g., trifluoromethyl, CF3); heterocyclic substituent. In another preferred embodiment according to this embodiment, the structure of the above-mentioned terminal-olefin-containing ligand on page 97 200909438 is as follows:
其中,Μ係為一過渡金屬且係選自下列族群之一者:釕 (ruthenium)、铑(rhodium)、鎢(tungsten)、銖(rhenium)、锇(osmium)、 銀(iridium)、翻(platinum)。R1係選自下列族群之一者:C1-C20炫 基、C1-C20環烧基、共耗芳香環基團(aromatic group) '雜芳香 雜環基團。R2〜R11可以相同或不同,且R2 ~ R11係獨立選自下列 族群之一者:氫原子(H)、鹵素原子(例如:氟'氯、溴、碘 烧基(alkyl group)、C1-C20 環烧基、烧氧基(alkoxyl group)、鹵素 取代的 C1-C20 烷基、C1-C20 取代的胺基(amino group)、C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20 醯胺基(amide group) '芳香基、鹵素取代的芳香基、鹵素取代的芳香烧基、鹵烧 基取代的芳香基、鹵烷基取代的芳香烷基、氰基(cyano)、硝基 (nitro)'共輛芳香環基團(aromatic group)、芳香雜環基團。 根據本範例,上述相鄰之R2與R3、R4與R5、R5與R6、R6與 R7、R8與R9、R9與R1G、R1G與R"等亦可以分別是形成一芳香環、 芳香雜環、環稀基或是雜環烯基之任意原子團。上述的芳香環、芳 香雜環、環稀基或是雜環稀基等可以分別是五元環、六元環、或是 第98頁 200909438 七元環。上述R2 ~ R7中未成環之取代基可以相同或不同,且上述 R2 ~ R7中未成環之取代基係獨立選自下列族群之一者:氫原子 (H)、鹵素原子、C1-C20烷基(alkyl group)、C1-C20環烷基、烷氧 基(alkoxyl group)、鹵素取代的C1-C20院基、C1-C20取代的胺基 (amino group)、C1-C20 醯基(acyl group)、C1-C20 酯基(ester group)、C1-C20醯胺基(amide group)、芳香基、鹵素取代的芳香基、 鹵素取代的芳香烷基、鹵烷基取代的芳香基、鹵烷基取代的芳香烷 ( 基、氱基(cyano)、硝基(nitro)、共耗芳香環基團(aromatic group )、 .¾ 芳香雜環基團。 上述芳香環、芳香雜環、環烯基或是雜環烯基等可以更包含一 個或多個取代基。上述芳香環、芳香雜環、環烯基或是雜環烯基等 之取代基可以相同或不同,且係獨立選自下列族群之一者:氫原子 (H)、鹵素原子(例如:氟、氯、溴、碘)、C1-C20烷基(alkylgroup)、 C1-C20環烧基、烧氧基(alkoxyl group)、_素取代的C1-C20烧基、 C1-C20 取代的胺基(amino group)、Cl-C20 醯基(acyl group)'Cl-C20 酯基(ester group)、C1-C20醯胺基(amide group)、芳香基、鹵素取 代的芳香基、函素取代的芳香烷基、鹵烷基取代的芳香基、鹵烷基 取代的芳香烧基、氰基(cyano)、硝基(nitro)、共轆芳香環基團 (aromatic group )、芳香雜環基團。 在根據本範例之結構中,Y係選自下列族群之一者:氮(N)、 碳(C)、氧(Ο)、硫(S)等原子。Y可以更包含一取代基。Q係為一至 第99頁 200909438 少包含二個原子之原子團 以構成一含氮雜環基團(heterocyclicWherein, the lanthanide is a transition metal and is selected from one of the following groups: ruthenium, rhodium, tungsten (tungsten), rhenium, osmium, iridium, Platinum). R1 is selected from one of the following groups: C1-C20 leuntyl, C1-C20 cycloalkyl, aroma group aromatic group heteroaromatic heterocyclic group. R2 to R11 may be the same or different, and R2 to R11 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom (for example, fluorine 'chlorine, bromine, an alkyl group, C1-C20 a cycloalkyl group, an alkoxyl group, a halogen-substituted C1-C20 alkyl group, a C1-C20 substituted amino group, a C1-C20 acyl group, a C1-C20 ester group (ester Group), C1-C20 amide group 'aryl group, halogen-substituted aryl group, halogen-substituted aromatic alkyl group, halogen group-substituted aryl group, haloalkyl-substituted aryl group, cyano group ( Cyano), nitro' a total aromatic group, aromatic heterocyclic group. According to this example, the adjacent R2 and R3, R4 and R5, R5 and R6, R6 and R7, R8 and R9, R9 and R1G, R1G and R" and the like may also be any atomic group forming an aromatic ring, an aromatic heterocyclic ring, a cycloaliphatic group or a heterocyclic alkenyl group, respectively. The above aromatic ring, aromatic heterocyclic ring, and ring-shaped ring The base or the heterocyclic group may be a five-membered ring, a six-membered ring, or a seven-membered ring of 200909438, respectively. The above R2 to R7 are not substituted by a ring. The same or different, and the unsubstituted substituents in the above R2 to R7 are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom, a C1-C20 alkyl group, a C1-C20 naphthenic ring. Alkoxyl group, halogen-substituted C1-C20 yard group, C1-C20 substituted amino group, C1-C20 acyl group, C1-C20 ester group , C1-C20 amide group, aryl group, halogen-substituted aryl group, halogen-substituted arylalkyl group, haloalkyl-substituted aryl group, haloalkyl-substituted aryl group (yl, cyano) , a nitro group, an aromatic group, a .3⁄4 aromatic heterocyclic group. The above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may further comprise one or a plurality of substituents. The substituents of the above aromatic ring, aromatic heterocyclic ring, cycloalkenyl group or heterocycloalkenyl group may be the same or different and are independently selected from one of the following groups: a hydrogen atom (H), a halogen atom. (eg, fluorine, chlorine, bromine, iodine), C1-C20 alkyl group, C1-C20 cycloalkyl, alkoxyl group, _ Substituted C1-C20 alkyl, C1-C20 substituted amino group, Cl-C20 acyl group 'Cl-C20 ester group, C1-C20 amide group , an aromatic group, a halogen-substituted aromatic group, a functionally substituted aromatic alkyl group, a haloalkyl-substituted aromatic group, a haloalkyl-substituted aromatic alkyl group, a cyano group, a nitro group, a conjugated aromatic group Aromatic group, aromatic heterocyclic group. In the structure according to the present example, Y is selected from one of the following groups: nitrogen (N), carbon (C), oxygen (oxime), sulfur (S), and the like. Y may further comprise a substituent. Q series is from one to 99. 200909438 A group of atoms containing two atoms is added to form a nitrogen-containing heterocyclic group (heterocyclic
取代的芳香基、 1不同’且上述取代基係獨立選自下列族群中之一 素原子(例如:氟、氯、溴、碘);芳香基、鹵素 鹵素取代的芳香烷基、_烷基取代的芳香基、鹵烷 基取代的芳香烷基、芳香基取代的cl_c2〇烷基;供電子基 (electron donating group)如 Cl-C20 燒基、cl_C2〇 環烧基(例如: 甲基、乙基、丁基'環己基)、C1-C20烧氧基(aik〇Xy group)、ci-C20 取代的胺基(amino group)、具有取代基的芳香胺基[例如苯胺基 (aniline)],拉電子基(electron withdrawing group)如鹵素、亞;ε肖酸基 (nitrile)、硝基(nitro)、羰基(carbonyl)' 氰基(cyano, —CN)與鹵素 取代的C1-C20烷基(例如三氟甲烷基,CF3);雜環取代基團。 根據本實施例,前述之芳香基團可以是包含苯基(phenyi)、萘 基(naphthyl)、聯苯基(diphenyl)、蒽基(anthryl)、苯并菲基(pyrenyi)、 菲基(phenanthryl)與第基(fluorenyl)或其他形式之多苯環取代基。 前述的環烯基團包含環己稀(cyclohexene)、環己二烯 (cyclohexadiene)、環戊稀(cyclopentene)與環戊二稀 (cyclopentadiene)或其他形式之環烯。前述之雜環基團包括派喃 (pyrane)、0辰略♦(pyrroline)、吱喃(furan)、苯并吱喃(benzofuran)、 噻吩(thiophene)、苯并噻吩(benzothiophene)、。比咬(pyridine)、啥琳 第100頁 200909438 (quinoline)、異喹琳(isoquinoline)、σ比嗓(pyrazine)、°密咬 (pyrimidine)、口比 口各(pyrrole)、口比哇(pyrazole)、口米哇(imidazole)、0引 0朵(indole)、售。坐(thiazole)、異0塞嗤(isothiazole) ' °惡°坐(oxazole)、 異11 惡唾(isoxazole)、苯并°塞峻(benzothiazole)、苯并°惡0坐 (benzoxazole)、二氮菲(phenanthroline)或其他形式之雜環。前述的 含氮雜環基團包含D比啶(pyridine)、喹琳(quinoline)、異喹淋 (isoquinoline)、"比嗪(pyrazine)、嘧咬(pyrimidine)、吡》各(pyrrole)、 f σ比吐(pyrazole)、咪唾(imidazole)、吲哚(indole)、嘆唾(thiazole)、 異噻唑(isothiazole) '噁唑(oxazole)、異噁唑(isoxaz〇ie)、笨并噻唑 (benzothiazole)、苯并鳴,坐(benzoxazole)與二氮菲(phenanthr〇line) 或其他形式之雜環。 形成電激發光元件的一般流程: 首先,於超音波震盪器中倒入體積比組成為中性清潔劑:去 (.離子水=1:50的清洗液以震盪清潔上述完成蝕刻之ίΤΟ破螭5分 鐘。接著,以軟毛刷刷洗上述之ΙΤΟ破璃並依序將其置於去離子 水以及電子級㈣震盈清潔5分鐘。之後,以氮氣吹乾上述之ιτ〇 玻璃。 將上述清潔後之ΙΤ〇玻璃置於-紫外光_臭氧機内5分鐘,取 出並固定在一基板上(ΙΤΟ面朝下)。接著,將上述之基板置入蒸 鍍機中並抽真空,直到腔體的真空度達到5xi〇_6 t〇rr時開始進行 第101頁 200909438 蒸鍍薄膜之步驟。蒸鍍薄膜時有機物鍍膜速率係控制於1〜2 A/s 之間,而金屬鍍膜之速率則係為鎂5 A/s且銀0.5人/ s ;其中,鎂/ 銀合金的比例為10: 1,且鎂銀共蒸鍍之金屬膜厚為55 nm。最後, 鍍一層100 nm的銀作為保護層。若金屬系統係選擇為氟化鋰/鋁系 統,則先以0.1人/s之速率蒸鍍氟化鋰並控制其膜厚為lnm ;接著, 鍍一層100 nm的鋁作為保護層。於上述之鍍膜期間,元件的旋轉 速率為20 rpm,且蒸鍍結束後等待20分鐘以便於金屬電極降溫; 接著,將腔體回充氮氣直至回復常壓。 另一方面,上述之電激發光元件製備完成後,藉由HitachF-4500 spectra scan spectrometer量測元件的電激螢光頻譜(EL spectra)與 CIE 座標圖(CIEcoordination),此外,藉由 Keithley 2400 programmable voltage-current source 量測元件的電流 (current )、電壓(voltage )與亮度(brightness )等性質。上述 之量測儀器皆在一大氣壓下室溫操作(約20°C)。Substituted aryl, 1 different 'and the above substituents are independently selected from one of the following groups of atoms (eg, fluorine, chlorine, bromine, iodine); aryl, halogen halogen substituted arylalkyl, _alkyl substituted Aromatic group, haloalkyl-substituted arylalkyl group, aryl-substituted cl_c2 alkyl group; electron donating group such as Cl-C20 alkyl group, cl_C2 anthracene ring group (for example: methyl group, ethyl group) , butyl 'cyclohexyl), C1-C20 alkoxy group (aik〇Xy group), ci-C20 substituted amino group, substituted aromatic amine group [eg aniline], Electron withdrawing group such as halogen, sub-; nitrile, nitro, carbonyl 'cyano, —CN, and halogen-substituted C1-C20 alkyl (eg Trifluoromethyl, CF3); heterocyclic substituent. According to this embodiment, the aforementioned aromatic group may be composed of phenyi, naphthyl, diphenyl, anthryl, pyrenyi, phenanthryl. And fluorenyl or other forms of polyphenyl ring substituents. The aforementioned cycloalkenyl group comprises cyclohexene, cyclohexadiene, cyclopentene and cyclopentadiene or other forms of cycloolefin. The aforementioned heterocyclic group includes pyrane, pyrroline, furan, benzofuran, thiophene, benzothiophene. Pyridine, 啥琳第100页200909438 (quinoline), isoquinoline, pyrazine, pyrimidine, pyrrole, pyrazole ), mouth imwa (imidazole), 0 to 0 (indole), for sale. Thiazole, isothiazole '°ox', oxazole, isoxazole, benzothiazole, benzoxazole, dinitrogen Phenanthroline or other forms of heterocyclic ring. The aforementioned nitrogen-containing heterocyclic group includes D pyridine, quinoline, isoquinoline, "pyazine, pyrimidine, pyrrole, f σ pyrazole, imidazole, indole, thiazole, isothiazole 'oxazole', isoxaz〇ie, stupid and thiazole (benzothiazole), benzopyrene, benzoxazole and phenanthr〇line or other forms of heterocyclic ring. The general flow of forming an electroluminescent device: First, pour the volume ratio into a neutral detergent in the ultrasonic oscillator: go to (Ion water = 1:50 cleaning solution to oscillate and clean the above-mentioned etching to complete the etching 5 minutes. Then, brush the above glass with a soft brush and place it in deionized water and electronic grade (4) for 5 minutes. Then, dry the above-mentioned ιτ〇 glass with nitrogen. The glass is placed in a UV-Ozone machine for 5 minutes, taken out and fixed on a substrate (face down). Next, the substrate is placed in an evaporation machine and evacuated until the vacuum of the chamber When the degree reaches 5xi〇_6 t〇rr, the step of vapor-depositing the film on page 101200909438 is started. When the film is deposited, the rate of organic coating is controlled between 1~2 A/s, and the rate of metal coating is magnesium. 5 A/s and silver 0.5 person/s; wherein the ratio of magnesium/silver alloy is 10:1, and the thickness of the metal film deposited by magnesium-silver is 55 nm. Finally, a layer of 100 nm silver is plated as a protective layer. If the metal system is selected as a lithium fluoride/aluminum system, first 0.1 At a rate of /s, the lithium fluoride is evaporated and the film thickness is controlled to be 1 nm; then, a layer of 100 nm of aluminum is applied as a protective layer. During the above coating, the rotation rate of the element is 20 rpm, and after the end of the evaporation, wait for 20 Minutes to facilitate the cooling of the metal electrode; then, the chamber is backfilled with nitrogen until the normal pressure is restored. On the other hand, after the preparation of the above-mentioned electroluminescent element, the electro-optic fluorescence of the measuring element is measured by the Hitach F-4500 spectra scan spectrometer. The spectrum (EL spectra) and the CIE coordinate diagram (CIEcoordination), in addition, the current (current), voltage (voltage) and brightness (brightness) of the component are measured by the Keithley 2400 programmable voltage-current source. All are operated at room temperature under atmospheric pressure (about 20 ° C).
Example 22.電激發光元件之性能比較 本範例將揭示數種根據本實施例之電激發光元件的較佳範例 之結構及其性質,然而,本說明書之範圍應以其後的專利範圍為 準,而不應以下列範例為限。 樣品元件結構(sample device structures) 本範例中所測試之各元件皆係為層狀結構,其結構示意圖係 第102頁 200909438 如第-圖中所示。本範例中所測試之各元件採用上述之肋玻璃作為基 板’並包含上述之含和麟配位基的職麵錯合物作為客體發光材料 (guest material)。另一方面,本範例藉由變化上述元件中的其他組成材料如 電極材料、主體發光材料(host material),以及電荷載子(charge carrier)傳輸層 材料以進行元件之性能測試。 其中’在電極的選擇方面,除使用Mg:Ag/Ag電極外,亦使用Example 22. Performance Comparison of Electroluminescent Device The present example will disclose the structure and properties of several preferred embodiments of the electroluminescent device according to the present embodiment. However, the scope of the specification should be based on the scope of the subsequent patent. It should not be limited to the following examples. Sample device structures Each element tested in this example is a layered structure, and its structure is shown on page 102. 200909438 as shown in the figure--. Each of the elements tested in this example employs the above-described rib glass as the substrate 'and contains the above-described face complex containing the chelating ligand as a guest material. On the other hand, the present example performs the performance test of the element by changing other constituent materials such as an electrode material, a host material, and a charge carrier transport layer material in the above elements. Where 'in the selection of the electrode, in addition to the use of Mg: Ag / Ag electrode, also used
LiF/ΑΙ電極進行測試;在主體發光材料的選擇方面,皆選用高能隙 及高三重態能量之材料如 mCP(3,5-Bis (N-carbaz〇lyl)benzene)、 CzSi(9-(4-ieri-butylphenyl)-3,6-bis (ίτ; phenylsilyl)-9/f-carbazole) ' BSB (4,4,-bis-triphenylsilanyl-biphenyl) 與 UGH2 〇?-bis(triphenyl- silyly)benzene),據此避免三重態能量自 摻雜物(dopant)逆傳回主體發光材料之三重態而降低元件效率,其 中,當使用BSB和UGH2為主體發光材料時,為減少電洞注入主體 發光材料的能障,故加入一mCP層;在電荷載子(charge carder)傳The LiF/ΑΙ electrode is tested; in the selection of the host luminescent material, materials with high energy gap and high triplet energy such as mCP (3,5-Bis (N-carbaz〇lyl)benzene), CzSi (9-(4) are selected. -ieri-butylphenyl)-3,6-bis (ίτ; phenylsilyl)-9/f-carbazole) 'BSB (4,4,-bis-triphenylsilanyl-biphenyl) and UGH2 〇?-bis(triphenyl-silyly)benzene) Therefore, the triplet energy is prevented from being reversely transmitted back to the triplet state of the host luminescent material to reduce the element efficiency, wherein when the BSB and the UGH2 are used as the main luminescent material, the body luminescent material is injected to reduce the hole injection. Energy barrier, so join a mCP layer; pass on the charge carder
輸層材料的選擇方面,係採用 BCPBCP is used in the selection of the material for the transport layer.
(2,9-Dimethyl-4,7-diphenyl-[l,l〇]phenanthroline )和 TPBI (2,9-Dimethyl-4,7-diphenyl-[l,l〇]phenanthroline)可做為電洞阻擔 層材料、或電洞阻擋兼電子傳輸層材料,其原因在於選擇寬能隙之 載子傳輸材料BCP、TPBI或mCP可抑制高能量之三重態激發子自主 體發光材料層擴散至載子傳輸層。上述之製作受測元件所使用之各 材料其化學結構係如第二圖所示。各受測試元件之詳細結構如下: 元件A : 第103頁 200909438 ITO/TCTA (40) / complex:mCP (7 %) (30)/BCP (15)/Alq (30)/ Mg:Ag/Ag 元件B : ITO/NPB (20)/ TCTA (10)/complex:CzSi (8 %) (30)/ BCP (15)/Alq (30)/ Mg:Ag/Ag 元件C : ITO/TCTA (30)/ mCP (20)/complex:BSB (7 %) (30)/BCP (10)/Alq (30)/ Mg:Ag/Ag 元件D : NPB (20)/TCTA (10)/ complex:CzSi (8 %) (30)/ TPBI (30)/LiF/Al ‘ 元件E : ITO/TCTA (40)/mCP (15)/complex:UGH2 (7 %) (30)/BCP (40) /Mg:Ag/Ag 元件F : ITO/TPD (20)/mCP (20)/complex:UGH2 (7 %) (30)/BCP (40) / LiF/Al 以上為元件A-F的組成’其中,各元件之陰極係為 Mg:Ag(55)/Ag(100),或是LiF(l)/Al(100)。上述各元件結構之厚度 單4立為nm。(2,9-Dimethyl-4,7-diphenyl-[l,l〇]phenanthroline) and TPBI (2,9-Dimethyl-4,7-diphenyl-[l,l〇]phenanthroline) can be used as electric resistance The carrier material, or the hole blocking and electron transport layer material, is because the carrier energy transport material BCP, TPBI or mCP with wide energy gap can suppress the diffusion of high energy triplet excitons from the host luminescent material layer to the carrier transport. Floor. The chemical structures of the materials used in the above-mentioned fabrication of the device under test are as shown in the second figure. The detailed structure of each tested component is as follows: Component A: Page 103 200909438 ITO/TCTA (40) / complex: mCP (7 %) (30) / BCP (15) / Alq (30) / Mg: Ag / Ag components B : ITO/NPB (20) / TCTA (10) / complex: CzSi (8 %) (30) / BCP (15) / Alq (30) / Mg: Ag / Ag Component C : ITO / TCTA (30) / mCP (20)/complex: BSB (7 %) (30)/BCP (10)/Alq (30)/ Mg: Ag/Ag Element D: NPB (20)/TCTA (10)/ complex: CzSi (8 % ) (30) / TPBI (30) / LiF / Al ' Component E : ITO / TCTA (40) / mCP (15) / complex: UGH2 (7 %) (30) / BCP (40) / Mg: Ag / Ag Element F: ITO/TPD (20)/mCP (20)/complex: UGH2 (7 %) (30)/BCP (40) / LiF/Al Above is the composition of the component AF', where the cathode of each component is Mg : Ag(55)/Ag(100), or LiF(l)/Al(100). The thickness of each of the above element structures is simply 4 nm.
K 樣品元件發光性能比較 各元件發光性能之測試結果比較係如下表一所示:K sample element luminescence performance comparison The test results of each component luminescence performance are compared as shown in the following table 1:
最大亮 度 (cd/m2) (電壓/ 伏特) /U ΊΤ货夕0 Ί王月b〜仪Maximum brightness (cd/m2) (voltage / volt) /U ΊΤ货夕0 Ί王月 b~仪
大光長m) 最放波(η 第104頁 200909438 伏特) Ir(pmi)2(pypz) A 4.3 8.4 (9.0) 25738 (14.5) 362.4 16.9 (9.0) 6.0 (8.5) (0.14,0.31) 486 B 4.2 7.9 (10.0) 13955 (16.0) 398.8 13.1 (10.0) 4.2 (9.5) (0.15,0.32) 486 Ir(pmi)2(tfpypz) A 6.0 5.6 (10.0) 7875 (16.0) 249.8 10.1 (10.0) 3.2(9.5) (0.14,0.26) 478 B 5.4 5.3 (11.0) 6346 (20.0) 193.2 9.8 (11.0) 3.0 (10.0) (0.14,0.26) 480 C 6.6 3.4 (12.5) 5721 (18.0) 386.3 5.5 (12.5) 1.4 (12.0) (0.14,0.22) 476 Ir(fpmi)2(pypz) B 4.1 8.0 (7.0) 9669 (15.0) 298.7 12.6 (7.0) 5.7 (6.5) (0.14,0.21) 472 C 4.6 7.5 (8.0) 8428 (13.5) 375.2 10.0 (B.0) 4.0 (7.5) (0.14,0.16) 466 D 5.2 6.2 (7.5) 6245 (14.5) 321.4 7.9 (7.5) 3.5 (7.0) (0.14,0.15) 464 E 6.8 8.8 (9.0) 3759 (20.0) 68.8 16.8 (9.0) 5.9 (9.0) (0.15,0.27) 478 Ir(fpmi)2(tfpypz) .1 B 5.3 3.1 (8.5) 2193 (13.0) 236.5 3.0 (8.5) 1.2 (7.5) (0.14,0.11) 458 C 6.2 4.9 (9.5) 3319 (17.0) 342.3 5.7 (9.5) 1.9 (9.5) (0.14,0.14) 464 D 5.2 2.6 (7.5) 2090 (13.0) 251.7 2.2 (7.5) 0.9 (7.5) (0.15,0.10) 452 E 6.2 4.4 (10.0) 3597 (16.0) 222.6 5.4 (10.0) 1.8(9.0) (0.14,0.14) 460 F 6.1 4.6 (9.5) 2671 (16.5) 272.4 2.7 (9.5) 0.98 (8.5) (0.14,0.09) 454 如表一中所示,光色較藍的Ir(fpmi)2(pypz)錯合物其元件最佳 效率>7%,此外,其CIE色度γ座標低於〇.2〇且落於純藍位置 第105頁 200909438 (0.14,0.16)。 另一方面,光色最藍的Ir(fpmi)2(tfpypz)錯合物其所搭配的主 體發光材料需要更高的三重態能量,因此Ir(fpmi)2(tfpypz)錯合物 只在以矽為主的主體發光材料(BSB、UGH2)方可得到較高的元件 效率。由表中可看出,在元件F結構下,Ir(fpmi)2(tfpypz)錯合物 其CIE色度座標可達到(0.14,0.09),同時元件效率接近5%。 - 顯然地,依照上面實施例中的描述,本發明可能有許多的修 正與差異。因此需要在其附加的權利要求項之範圍内加以理解,除 了上述詳細的描述外,本發明還可以廣泛地在其他的實施例中施 行。上述僅為本發明之較佳實施例而已,並非用以限定本發明之申 請專利範圍;凡其它未脫離本發明所揭露之精神下所完成的等效改 變或修飾,均應包含在下述申請專利範圍内。 'i 第106頁 200909438 【圖式簡單說明】 第一圖係為電激發光元件結構示意圖;以及 第二圖係為電激發光元件製作材料之化學結構示意圖。【主要元件符號說明】 / \ 第107頁Large light length m) Most oscillating (η page 104 200909438 volts) Ir(pmi)2(pypz) A 4.3 8.4 (9.0) 25738 (14.5) 362.4 16.9 (9.0) 6.0 (8.5) (0.14, 0.31) 486 B 4.2 7.9 (10.0) 13955 (16.0) 398.8 13.1 (10.0) 4.2 (9.5) (0.15, 0.32) 486 Ir(pmi)2(tfpypz) A 6.0 5.6 (10.0) 7875 (16.0) 249.8 10.1 (10.0) 3.2 (9.5 (0.14,0.26) 478 B 5.4 5.3 (11.0) 6346 (20.0) 193.2 9.8 (11.0) 3.0 (10.0) (0.14,0.26) 480 C 6.6 3.4 (12.5) 5721 (18.0) 386.3 5.5 (12.5) 1.4 (12.0 (0.14,0.22) 476 Ir(fpmi)2(pypz) B 4.1 8.0 (7.0) 9669 (15.0) 298.7 12.6 (7.0) 5.7 (6.5) (0.14, 0.21) 472 C 4.6 7.5 (8.0) 8428 (13.5) 375.2 10.0 (B.0) 4.0 (7.5) (0.14, 0.16) 466 D 5.2 6.2 (7.5) 6245 (14.5) 321.4 7.9 (7.5) 3.5 (7.0) (0.14, 0.15) 464 E 6.8 8.8 (9.0) 3759 ( 20.0) 68.8 16.8 (9.0) 5.9 (9.0) (0.15, 0.27) 478 Ir(fpmi)2(tfpypz) .1 B 5.3 3.1 (8.5) 2193 (13.0) 236.5 3.0 (8.5) 1.2 (7.5) (0.14, 0.11 ) 458 C 6.2 4.9 (9.5) 3319 (17.0) 342.3 5.7 (9.5) 1.9 (9.5) (0.14, 0.14) 464 D 5.2 2.6 (7.5) 2090 (13.0) 251.7 2.2 (7.5) 0.9 (7.5) (0.15,0 . 10) 452 E 6.2 4.4 (10.0) 3597 (16.0) 222.6 5.4 (10.0) 1.8 (9.0) (0.14, 0.14) 460 F 6.1 4.6 (9.5) 2671 (16.5) 272.4 2.7 (9.5) 0.98 (8.5) (0.14, 0.09) 454 As shown in Table 1, the light-colored Ir(fpmi)2(pypz) complex has an optimum component efficiency of 7%, and in addition, its CIE chromaticity γ coordinate is lower than 〇.2〇 And fall in the pure blue position on page 105 200909438 (0.14, 0.16). On the other hand, the blue-colored Ir(fpmi)2(tfpypz) complex of the light color requires a higher triplet energy for the host luminescent material, so the Ir(fpmi)2(tfpypz) complex is only矽-based main body luminescent materials (BSB, UGH2) can achieve higher component efficiency. As can be seen from the table, under the F structure, the Ir(fpmi)2(tfpypz) complex has a CIE chromaticity coordinate of (0.14, 0.09) and a component efficiency of approximately 5%. - Obviously, the invention may have many modifications and differences in accordance with the description in the above embodiments. Therefore, it is to be understood that the scope of the appended claims are intended to be The above are only the preferred embodiments of the present invention, and are not intended to limit the scope of the claims of the present invention; any equivalent changes or modifications made without departing from the spirit of the invention should be included in the following patents. Within the scope. 'i Page 106 200909438 [Simple description of the diagram] The first diagram is a schematic diagram of the structure of the electroluminescence element; and the second diagram is a schematic diagram of the chemical structure of the material of the electroluminescence element. [Major component symbol description] / \第107页
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW096132017A TWI388566B (en) | 2007-08-29 | 2007-08-29 | Transition metal complexes with carbene ligands and their application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW096132017A TWI388566B (en) | 2007-08-29 | 2007-08-29 | Transition metal complexes with carbene ligands and their application |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200909438A true TW200909438A (en) | 2009-03-01 |
TWI388566B TWI388566B (en) | 2013-03-11 |
Family
ID=44724006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096132017A TWI388566B (en) | 2007-08-29 | 2007-08-29 | Transition metal complexes with carbene ligands and their application |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI388566B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA54133B1 (en) | 2018-03-08 | 2022-01-31 | Incyte Corp | Aminopyrazine diol compounds used as pi3k-y inhibitors |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
-
2007
- 2007-08-29 TW TW096132017A patent/TWI388566B/en active
Also Published As
Publication number | Publication date |
---|---|
TWI388566B (en) | 2013-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5135660B2 (en) | Organic electroluminescence device | |
CN105418591B (en) | Stable emitter | |
JP4284169B2 (en) | Red light emitting compound and organic electroluminescent device employing the same | |
US7862908B2 (en) | Conjugated compounds containing hydroindoloacridine structural elements, and their use | |
TWI498412B (en) | Arylamine compound | |
Xu et al. | Synthesis and properties of iridium complexes based 1, 3, 4-oxadiazoles derivatives | |
TWI313292B (en) | Light-emitting element and iridium complex | |
JP5723764B2 (en) | Organic electroluminescence device | |
Schrögel et al. | Meta-linked CBP-derivatives as host materials for a blue iridium carbene complex | |
TWI506030B (en) | Transition metal carbene complexes and the electroluminescent application thereof | |
JP5154639B2 (en) | Naphthylcarbazole derivative, KL host material, organic electroluminescent element using the same, display device and lighting device using the same | |
KR20050052473A (en) | Organic light emitting materials and devices | |
Cui et al. | A simple systematic design of phenylcarbazole derivatives for host materials to high-efficiency phosphorescent organic light-emitting diodes | |
TWI549942B (en) | N-phenyl triscarbazole | |
TW200540245A (en) | Improved electroluminescent stability | |
TW200840408A (en) | Light-emitting device | |
JP4816610B2 (en) | Organic electroluminescence device | |
US7960547B2 (en) | Transition metal complexes with carbene ligands and their application | |
JP2005044802A (en) | Organic light emitting diode | |
Li et al. | Multifunctional phosphorescent iridium (III) complexes based on 2-phenylbenzothiazole derivative for highly efficient organic light-emitting diodes | |
TWI390007B (en) | Triptycene derivatives and their application | |
KR101369662B1 (en) | New Compounds, KL Host Material And Organic Light Emitting Device | |
JPWO2005003095A1 (en) | Metal complex compound and organic electroluminescence device using the same | |
TW200909438A (en) | Transition metal complexes with carbene ligands and their application | |
KR101519504B1 (en) | Carborane compound containing charge transport material for blue phosphorescent, and blue phosphorescent organic light emitting device containing it |